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 : - : : -ABSTRACT
 
, The objective of this: study is to- evaluate the : ­
impact, of the Diabetes Nurse Care Manager on an at-risk
 
diabetic population using a Primary Care Group Visit
 
Model.in Outlying Medical.Offices within the
 
Kaiser-Permanente Health Care::S upon the process and
 
outcome , of care-in this, pppulatidn,.
 
This study was'pefformed in the primary Care Clinics
 
of a large group-model Health Maintenance Organization ,
 
, ,(HMO:) in Southern California. Poorly controlled diabetic :
 
members > 30.years of age were selected for a nurse. ,
 
management intervention .based upon elevated .Hemoglobin
 
Ale (HbAlc) values of. 8.9% and higher,- These patients
 
attended least one nurse managed group visit appointment
 
in their Local Medical Office with their Primary Care
 
Physician acting as a figure of authority. Tjie Care
 
Management - nurse-, subsequently .followed each individual
 
patient by phone in order to improve patient, adherence to
 
Clinical Practice Recommendations..
 
In a three and six month analysis, the intervention
 
group had significantly improved its Outcome Parameters
 
for Quality of Care. HbAlc, which is a clinical marker
 
for diabetes control, improved by 23.9% in three,months
 
ill
 
and improved by 27.8% in six months. Surrogate Parameters
 
for long-term Quality Measures,such as Urinary
 
Microalbumin, LDL-Cholesterol, and Retinal Screening
 
Examinations also improved.
 
A Primary Care Group Visit Model that utilized.a
 
Diabetes Nurse Care Manager in a shared-practice
 
situation with the Primary Care Doctor in the Outlying
 
Medical Offices has demonstrated improved Quality of Care
 
delivered to at-risk diabetic patients.
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CHAPTER ONE
 
PROPOSAL
 
Introduction
 
Diabetes is a chronic, sometimes debilitating,
 
disease. Based upon research reported in the Diabetes
 
Control and Complications Trial [DCCT] (1993) as well as
 
the UK Prospective Diabetes Study [UKPDS] (1998),
 
improved diabetic control of blood sugars , has helped
 
decrease the incidence of certain long-term
 
complications. The monitoring of yearly retinal screening
 
examinations. Hemoglobin Ale (HbAlc), Urinary
 
Microalbumin (MA), and Low-Density-Lipoprotein (LDL)
 
Cholesterol all contribute to improved clinical outcomes.
 
Greenfield, Rogers, Mangotich, Carney, and Tarlov (1995),
 
McCullough, Price, Hindmarsh and Wagner (1998), and many
 
others, have shown that any method that improves
 
compliance with routine monitoring and treatment will
 
translate into improved health status for the patient.
 
Recently, Martin, Selby, and Zhang (1995) and Ho,
 
Marger, Heart, Yip, and Shekelle (1998) have shown that
 
most health-care organizations approach the challenges of
 
monitoring and screening for diabetes complications in a
 
haphazard manner. The implementation of computerized
 
databases used to manage large numbers of people with
 
chronic conditions is still in its infancy. According to
 
Frame (1995) there are no set standards for their usage.
 
The point is well made by Ornstein, Garr, Jenkins,
 
Musham, Hamadeh, and Lancaster, (1995) that the majority
 
of these Computerized Decision Support Systems (CDSS) are
 
compartmentalized in large, centralized Diabetes Care
 
Specialty Clinics. Paradoxically, it is the Primary Care
 
Practitioner that reguires this data tool to help manage
 
the relatively well-controlled diabetic patient before
 
he/she becomes a high-risk diabetic patient.
 
Wagner (1998) concluded that the role of Diabetes
 
Nurse Educators and Diabetes, Nurse Care Managers is a
 
field in evolution. The Nursing Scope of Practice (2000),
 
which allows a Registered Nurse the capacity to monitor
 
and modify treatment regimens on an individual basis, has
 
undergone a great metamorphosis in recent years. These
 
highly trained professionals must constantly use their
 
skills for assessing compliance, determining the degree
 
of diabetes control, and changing treatment parameters in
 
the course of managing those patients under their care.
 
The research of Aubert et al. (1998) and others has
 
demonstrated that Diabetes Nurse Care Managers have
 
proven to be the best resources for following diabetic
 
patients through the use of large computerized databases.
 
Their skills include Case Finding the optimal population
 
to be followed, contacting the Primary Care Physician
 
(PCP) and diabetic patient in order to initiate Case
 
Management, and performing the. actual psychoeducational
 
and management interventions during the course of
 
treatment.
 
The presence of computerized Clinical Patient
 
Registries such as those evaluated in the study by Shea,
 
Du Mouchel, and Bahamonde (1996), in addition to detailed
 
Clinical Practice Guidelines (CPG), and precise Policies
 
and Procedures (P&P) for delivering diabetes care have
 
provided the ideal manner for improving the quality of
 
diabetic care in the managed-care environment. The
 
combination of these tools together with Computerized
 
Decision Support Systems and a functioning Electronic
 
Health Record (ERR) as documented by Baker, Lafata, Ward,
 
Whitehouse, and Divine, (2001) have vastly improved our.
 
proactive approach to diabetes care. Batalden et al.,
 
(1997) have demonstrated that the data generated from
 
these electronic databases should form the basis of a
 
Continual Quality Improvement approach to managing a
 
large group of diabetic patients. The national
 
organizations responsible for monitoring the quality of
 
care within large healthcare systems, such as the
 
National Committee for Quality Assurance (NCQA), have
 
begun to require the measurement of such data and the
 
creation of systems for maintaining and improving the
 
quality of care being delivered.
 
Statement of the Problem
 
As Physicians become more and more overworked, their
 
time spent per patient goes down. Physicians are unable
 
to fully-educate their diabetic patients, and therefore
 
have delegated this duty to the Diabetes Nurse Educator.
 
The Diabetes Educator, as described in the work of
 
Peters, Davidson, and Ossorio (1995), has become a
 
Physician Extender in the sense of monitoring laboratory
 
results and ordering routine lab testing for the
 
specialty clinics supporting the work of the Primary Care
 
Provider. However, the full use of Diabetes Nurse
 
Educators in the Outlying Medical Offices was never
 
realized in the past due to resource and staffing
 
limitations within the Fontana Diabetes Care Clinic.
 
Primary Care Physicians are now becoming even more
 
interested in improving care and outcomes in their
 
diabetic populations. The British studies by Pringle,
 
Ward, and Chilvers (1993), Farmer and Coulter (1990), and
 
Koperski (1992) show that the development of the
 
"mini-clinic" is a movement toward providing much more
 
than routine care in Outlying Medical Offices.
 
In following the Clinical Practice Recommendations
 
(2001) of the American Diabetes Association (ADA), we
 
find that routine care for persons with diabetes should
 
consist of yearly monitoring of Hemoglobin Ale, Urinary
 
Microalbumin, Low-Density-Lipoprotein Cholesterol, and
 
Retinal Screening Examinations. In addition, there should
 
be feedback of pertinent information to the patient in
 
order to initiate any necessary changes in diabetes
 
treatment. This is usually followed up with an assessment
 
of the patient's response to the new treatment and the
 
need for further treatment. However, the work of Khoury,
 
Churgin, and Strawn, (1998) demonstrates.that Physician
 
compliance with the many Clinical Practice Guidelines.
 
(CPG) that they are required to be familiar with has been
 
diminishing due to lack of available time and. the
 
proliferation of multiple new guidelines. Physicians are
 
increasingly unable to provide this care on their own and
 
within a reasonable amount of time.
 
Diabetes Nurse Care Managers are individuals that
 
have, in the past, provided basic educational
 
interventions, individual consultations, and formalized
 
medication management in a highly structured and
 
centralized hospital clinic environment. Their role is
 
changing as the population of people with diabetes within
 
any given healthcare organization becomes better defined.
 
Wagner, Austin, and Von Korff, (1996) again has shown
 
that the higher-risk patients need more direct care.
 
Those patients in most need of care are often those who
 
do not keep their appointments in a standard clinic
 
setting. Therefore, changing the venue in which the care
 
is delivered back to the Primary. Physician's office has
 
become a useful adjunctive treatment to routine diabetes
 
care. However, no one has determined the impact of this
 
intervention on the overall quality of care delivered to
 
a higher-risk diabetic population.
 
Need for the Study
 
This study has been designed to assess the
 
effectiveness and impact of allocating Diabetes Nurse
 
Care Managers to Outlying Medical Offices of the
 
Kaiser-Permanente Health Plan in the Fontana Service
 
Area. This study has helped to determine whether the
 
allocation of Clinical Nurse Educator resources to the
 
outlying clinics improves the parameters associated with
 
good quality diabetes care. There is still a need for
 
subsequent research upon potential savings, benefits,
 
limitations, and trade-offs associated with this change
 
in resource allocation. In addition, this model of care
 
must directly or indirectly benefit the Physicians in the
 
medical offices in which the care is delivered.
 
Furthermore, in order to continue this model of care,
 
there must be an assessment of satisfaction of the
 
patients, since profound patient dissatisfaction would
 
hinder long-term compliance with the requirements
 
mandated for quality patient care.
 
Regulatory agencies such as the National Committee
 
for Quality Assurance have begun to require studies of
 
impact and quality of care when assessing the .
 
effectiveness of large managed healthcare agencies with
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defined patient populations. This study helps meet the
 
needs of these agencies as well as the needs of the
 
Department of Preventive Medicine in which these Diabetes
 
Nurse Care Managers function. Additionally, this
 
information has permitted the Department of Preventive
 
Medicine to demonstrate value to the Medical Group
 
Administrative Team in Fontana.
 
Scope and Limitations
 
This study has been conducted entirely with members
 
of the Kaiser Health Plan that are managed by the
 
Southern California Permanente Medical Group (SCPMG).
 
There are over 3 million lives covered by the
 
Kaiser-Permanente Health Care System in Southern
 
California. In the Fontana Medical Service Area there are
 
approximately 371,000 active members. Of this number
 
there are 15,482 individuals (4.2 percent) identified as
 
having Diabetes Mellitus. A nonrandomized longitudinal
 
study was conducted on a subset of this population being
 
followed in the Outlying Medical Offices of Colton and
 
Victorville in the Fontana Medical Service Area. All
 
participants were over 18 years of age and had been
 
Kaiser Health Plan members continuously for the one year
 
preceding enrollment In this study.
 
The patients being studied had been chosen only for
 
those Physicians that wished to participate In a
 
shared-practice group visit model of care In which a
 
Diabetes Nurse Care Manager helped that Physician manage
 
a higher-risk subset of his/her diabetic patients. There
 
Is Insufficient evidence to note whether cooperative
 
physicians have better or worse outcomes with their
 
diabetic patients. Therefore, this population must be
 
considered to be a nonrandomlzed sample.
 
In addition, the choice of selecting a range of
 
Hemoglobin Ale from 9.0 and above to represent a
 
higher-risk group was arbitrarily based upon the Health
 
Plan Employer Data and Information Set (HEDIS, 2000)
 
measures demonstrating poor vs. acceptable control for
 
diabetic Health Plan members whose Hemoglobin Ale was
 
at-rlsk of exceeding the threshold value of 9.5%.
 
The patients that participated In this
 
shared-practice model had agreed to come to one physician
 
visit during which the Diabetes Nurse Care Manager
 
explained his/her role and limitations. He/she also
 
discussed general Diabetes Care Guidelines with the
 
participating members. This could lead to some degree of
 
bias towards ambulatory patients or patients with
 
available transportation. The work of Wagner et al.,
 
(2001) at the Group Health Cooperative of Puget Sound
 
demonstrated that patients with good family or community
 
resources tend to do better in their diabetes care than
 
do those patients who do not have these resources.
 
In the course of this dissertation, the issues of
 
patient compliance, general authority figures as well as
 
time and place utility have been discussed in the context
 
of the study layout. Discussion of group dynamics and
 
educational interventions also plays a significant part
 
in describing the full impact of this study. The
 
importance of Provider - Patient communication and timely
 
feedback of results also plays an important role in the
 
final discussion.
 
Sampling Plan
 
The population for this study was defined through a
 
Care Management tool (POINT) developed by Pharmacy
 
Analytic Systems within Kaiser-Permanente. This database
 
system allowed queries to be undertaken on the Southern
 
California Region-wide Diabetes Registry. The Medical
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Center's and the individual Physician's diabetes panel
 
was easily identified using this tool. A list of those
 
patients with a Hemoglobin Ale greater than 8.9% were
 
presented to their Primary Care Physician for approval.
 
If approved, these patients were then contacted by phone
 
and/or letter asking them to participate in a two-hour
 
doctor's visit in which several individuals would address
 
their diabetes management. It is at this point that some
 
individuals were excluded by refusal, educational
 
barrier, or language barrier. These individuals were then
 
offered one-to-one counseling and management by a
 
culturally appropriate Physician or Nurse Educator.
 
When the group of selected members met with the
 
Diabetes Nurse Care Manager and their Primary Physician,
 
they received an educational intervention, followed by a
 
review of their medical treatment and pertinent
 
laboratory testing. Those patients that needed any
 
changes in medication got those changes made on the spot.
 
Pertinent laboratory tests were ordered and performed the
 
same day. The Diabetes Nurse Care Manager was responsible
 
for informing his/her patients of the results of their
 
tests and maintaining phone and letter contact with
 
his/her patient population for at least one-year.
 
11 ' • .
 
However, for the purpose of this study, each patient
 
population was studied for six months prior to their
 
intervention as well as six months after their
 
intervention.
 
The data collected on each patient by each nurse at
 
every intervention was recorded in a clinical diabetes
 
database that served as an Electronic Health Record
 
(EHR). Further data for this study were available on
 
legacy mainframe computers that compiled administrative
 
data, as well as demographic, , laboratory, pharmacy, and
 
hospitalization data for the members of the Kaiser Health
 
Plan.
 
Methods and Procedures
 
The population already discussed had been followed
 
for improvement in their surrogate care parameters
 
(Frequency of performing HbAlc, MA, and LDL-Cholesterol)
 
as a measure of their quality of care. During the course
 
of the study any changes in these parameters have been
 
attributed to the Nurse Care Manager intervention as
 
these patients were receiving routine care prior to their
 
intervention. In addition, all participants had been
 
continuously enrolled in the Kaiser Health Plan for the
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one-year preceding this study.thus allowing direct
 
comparisons to take place within each group.
 
In order to demonstrate statistically significant
 
changes in Hemoglobin. Ale frequency. Urinary Microalbumin
 
frequency, LDL-Cholesterol frequency, as well as changes
 
in HbAlc values;, an Average Frequency, Analysis of
 
Variance (ANOVA), and/or t-test has been calculated for
 
each parameter. To control for the patient's expected
 
likelihood of receiving the routine care and screening
 
tests, these patients have been compared to their own
 
previous lab values prior to the Care Management
 
intervention.
 
Additional data was collected on the frequency of
 
performing yearly Diabetic Retinal Screening
 
Examinations. This data was compared to regional averages
 
within the Kaiser-Permanente Health Care system as well
 
as to national averages for other health care plans. That
 
data is available through the National Committee for
 
Quality Assurance (HEDIS, 2000).
 
Data on the presence of abnormal urinary
 
Microalbumin and abnormal LDL-Cholesterol were obtained
 
through the POINT Care Management tool. This data tool
 
also provided information on whether each patient had
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received pharmaceutical treatment for his or her clinical
 
laboratory abnormality. That data was also compared with
 
National and Regional averaged data.
 
Brief Summary
 
This study was designed to help answer the question
 
on whether allocating Diabetes Nurse Care Managers to
 
outlying Medical Offices is effective in improving care
 
to diabetic members of Kaiser Permanente by evaluating
 
the frequency of testing Hemoglobin Ale, Urinary
 
Microalbumin, and LDL-Cholesterol for a six month period
 
before and a six month period after initiation of
 
Diabetes Care Management in outlying Medical Offices. The
 
Hemoglobin Ale value has also been used to help assess
 
the degree of improvement in diabetes control during the
 
course of this study. This study also helps determine
 
whether Diabetes Nurse Educator resources shall continue
 
to be allocated to Outlying Medical Offices and whether
 
this model of care should be expanded in the future. The
 
business case for expansion will be presented to the
 
administrative team at the Fontana Kaiser-Permanente
 
Medical Center.
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 CHAPTER TWO
 
REVIEW OF THE LITERATURE
 
' Historical Background
 
Since this study is based upon the evaluation or a
 
new method of care delivery within the Department of
 
Preventive Medicine at the Kaiser Permanente Medical
 
Center in Fontana, California, it is obligatory to look
 
at what has come before in order to fully understand the
 
impact of the ongoing process of change.
 
In the past. Preventive Medicine has been the
 
department that provided health education and training to
 
people with identified disease processes and disease
 
risks in order to modify behavior toward a more healthful
 
lifestyle. This function was provided by Health .
 
Educators, nurses, dieticians, and behavioral specialists
 
who used commonly available educational tools, such as
 
classroom instruction, individual instruction, books,
 
pamphlets, and handouts. These goals were defined by
 
getting the greatest number of identified people to
 
classes. The greatest problem that arose with the
 
traditional educational function of Preventive Medicine
 
was that there were no measurable clinical outcomes (just
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educational outcomes), and that the people with the most
 
need for any intervention were almost always the ones who
 
never came to the classes. Over time, other health plans
 
scaled back their Preventive Medicine Departments to
 
reflect a subordinate role in the health care system. In
 
discussion with others, I have learned that Preventive
 
Medicine Departments frequently consisted of a single
 
person who coordinated classes and mailings. The lack of
 
a consistent business case hurt the development and
 
growth of Preventive Medicine in the past. The lack of
 
defined populations of people with a disease or disease
 
risk posed another great obstacle to the development of
 
modern Preventive Medicine. It was the growing use of
 
Information Technology that helped bring the science of
 
Preventive Medicine to the forefront of medical science.
 
Dr Eric Ngo began the Preventive Medicine Department
 
at the Kaiser Permanente Medical Center in Fontana,
 
California in 1976. He had the support of Kaiser Health
 
Plan as well as the Medical Group Administration to place
 
the multiple functions of Preventive Medicine beneath one
 
roof. This served to coordinate and integrate the
 
delivery of Preventive care as well as allow innovation
 
in the design of preventive care programs. Dr Ngo hired
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nurses and educators with good,clinical backgrounds since
 
they would have an existing store of knowledge to share
 
with our at-risk patient population. These core
 
individuals became the innovators of new models of
 
preventive care delivery.
 
The nurses and physicians in Preventive Medicine
 
forever changed the diabetes program. In 1979, Marli
 
Crane RN, MFT had attended a lecture by Dr. Mayer
 
Davidson describing a concept of using Registered Nurses
 
to advise patients on how to use their diabetic
 
medications properly. This involved changing insulin
 
dosages based upon an algorithm prescribed by a treating
 
physician. This Model of Care, which Davidson et al.,
 
(1998) described in subsequent papers, placed more
 
responsibility upon the nurse and actively included nurse
 
educators in the treatment portion of care. Over time,
 
these nurses developed the skills involved for using most
 
of the medications needed in diabetes management.
 
Algorithms on standing orders enabled a much greater
 
participation by the Nurse Educator in the practical care
 
of our diabetic patients.
 
The traditional concept of Preventive Medicine was
 
extended to its logical limits within the next eight
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years. In 1987,. a comprehensive treatment team was formed
 
to treat diabetes and its many complications. An MD
 
Endocrinologist was hired to improve the health of all
 
diabetic Kaiser Health Plan members. This meant that the
 
role of Preventive Medicine would have to be extended to
 
outreach to all people affected by diabetes, A means of
 
identifying those people affected by diabetes had yet to
 
be developed. However, planning was begun to convert a
 
system of paper charting to an electronic record of all
 
diabetic members. This would at least create a list of
 
people identified with diabetes who have been referred to
 
the Preventive Medicine Department. This would form the
 
core of what would become a complete registry of all
 
Kaiser Health Plan members with diabetes in the Fontana
 
Service Area.
 
The Fontana Diabetes Team in 1987 consisted of one
 
(1) MD Endocrinologist, five (5) Diabetes Nurse
 
Specialists that obtained Certified Diabetes Educator
 
(ODE) credentials, one (1) Registered Dietitian (RD) who
 
obtained ODE certification, and the staff of Preventive
 
Medicine for program support (one (1) MD Chief of
 
Department, one (1) Department Administrator (DA), three
 
(3) PHD Doctors of Health Science, three (3) Registered
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Dietitians, three (3) Certified Health Educators, and
 
their clerical support). During this period of time,
 
diabetes care was expanded into perinatal care, which
 
includes gestational and pre-gestational diabetes care.
 
The team became capable of handling complex cases,
 
including people on insulin pumps. However, the major
 
change was focus on diabetic complications rather than
 
glucose numbers and glucose control. This shift in
 
emphasis meant that more resources would be needed to
 
identify at-risk individuals and target specific
 
treatments. In 1989, Dr Gary Wong became a member of the
 
Department of Preventive Medicine. His background with a
 
Masters in Public Health gave the department the skills
 
needed to actually create a patient tracking system for
 
diabetes. The greatest difficulty in creating such a
 
system was to create the database structure to store the
 
information needed to identify and follow this patient
 
population. Meetings between Dr Wong and the
 
Endocrinologist, Dr. Edward Hess, resulted in a
 
clinically useful tool for managing an identified
 
diabetic population. The missing step was to identify
 
diabetic members who had not been referred to the
 
Preventive Medicine Department. This relational database
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had many features that allowed improved patient
 
identification and tracking. Laboratory data was
 
downloaded into the database to allow tracking of
 
critical valves for diabetes management. Communication
 
between the patient and the department improved with the
 
use of a letter generation function.
 
Between 1993 and 1995, a similar system was created
 
on a region-wide scale. A Diabetes Registry was generated
 
from laboratory pharmacy, hospital, and emergency
 
department data. This was to be used to provide
 
compliance data for national quality standards data
 
collection. That system has evolved into a regional
 
repository of diabetes data that allows a comparison
 
within a Medical Service Area as well as between Medical
 
Service Areas, as well as between various Health Plans.
 
From 1995 onward, other Medical Centers within the
 
Southern California Permanente Medical Group had
 
developed patient tracking systems. Most of these systems
 
also had means of tracking changes in laboratory values
 
and clinical complications. The major differences were in
 
the manner in which this.data was used to improve patient
 
care, and the allocation of resources required to provide
 
that care within each Medical Service Area.
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From 1995 to 2000, the role of the Diabetes Nurse
 
Specialist had shifted slowly toward becoming a Care
 
Manager. The nurse had become a vital partner in the
 
ongoing care of people with chronic conditions. The
 
algorithms for changing insulin dosages had expanded to
 
full Policies and Procedures that helped identify people
 
at-risk for stroke, heart attacks, or renal failure.
 
Assisting people in obtaining proper treatment for
 
diabetic complications permitted earlier diagnosis and
 
treatment. This treatment is essential in preventing
 
progression of serious complications. The focus on
 
Population Care Management (PCM) required that nurses
 
become aware of other co-morbid states that occur more
 
frequently in the diabetic population. That stage was
 
begun in the year 2000, as changes were initiated in the
 
Department of Preventive Medicine to help coordinate
 
simultaneous care in multiple disease states.
 
In that year, efforts were made to coordinate the
 
Care Management areas of Diabetes Mellitus (DM), Coronary
 
Artery Disease (CAD), Congestive Heart Failure (CHF), and
 
Asthma (as well as Elder Care, End Stage Renal Disease
 
[ESRD], and Perinatal Care). These efforts resulted in
 
greater understanding and greater cooperation among these
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 Care Management areas. Ultimately .the nurses involved in
 
care managing. Diabetes Mellitus,;.Coronary Artery Disease,
 
Congestive Heart Failure, and Asthma have all joined the
 
Department of : Preve'ntive . Medicine in tracking,
 
preventing, and managing the progression of chronic,
 
diseases. An important Component of.the care management
 
model of care is Continuous Quality Improvement (CQI) and
 
feedback of results. That has formed the basis of the .
 
present goals.and objectives of the. Preventive Medicine
 
Department in Fontana.
 
Finally, by 2001, the expertise in care management .
 
was beginning to produce results in developing a new
 
model of diabetes care. Diabetes Nurse Specialists.were
 
cross-training in cholesterol management and had begun to
 
interact with other care managers in other departments. A
 
Registered Nurse Practitioner (RNP) was hired to address
 
more complex cardiac cases. All the nurses and Clinical
 
Health Educators were trained in computerized outreach
 
toward defined disease populations. The staff of
 
Preventive Medicine was always included in the
 
development of this new model of care. Eventually, the
 
lingering problem of reaching the at-risk individual was
 
addressed by this present study. "How does one reach the
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person with difficult to control diabetes when
 
transportation or time constraint hinders care?
 
Implementation of Preventive Services
 
Since Preventive Medicine had evolved from a purely
 
Public Health perspective and educational perspective, it
 
is important define the arena in which Preventive
 
Medicine operates. The definition of Preventive Medicine
 
as it appears in Stedman's Medical Dictionary (1972) is
 
"a medical specialty primarily concerned with prevention
 
or disease and the promotion and preservation of health
 
in the individual", has given way to a more comprehensive
 
and outreaching definition used by the Accrediting
 
Council for Graduate Medical Education (Green Book) 2000.
 
"The primary foci of Preventive Medicine are the study of
 
disease processes as they occur in communities and
 
defined population groups, and the stimulation of
 
practices with respect to the community and the
 
individual that will advance health by promoting health
 
enhancing environments and behaviors, so preventing
 
disease and injury, making possible early diagnosis and
 
treatment, and fostering habilitation and rehabilitation
 
of persons with disabilities."
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The major changes in definition center around the
 
study of defined population groups, the involvement of
 
entire disease processes, and the outreach involved in
 
promoting health within these populations. This has
 
formed the basis for developing goals and objectives for
 
the Department of Preventive Medicine in Fontana. First
 
and foremost, we must strive to improve the health of all
 
our diabetic members. This population numbers
 
approximately 15,482 people using data derived from our
 
diabetes population registry. Second, we must provide
 
comprehensive diabetes education and training in addition
 
to all other activities. Third, we must continue to
 
supply over 2000 individual appointments per year and
 
over 3000 class and group appointments. Fourth, we will
 
continue to receive over 2200 new referrals per year that
 
add to our population. Fifth, we will start over 500
 
people on insulin this year and follow up on their
 
education and management. Sixth, Care Management
 
initiatives have now included the ability to outreach to
 
groups we have missed in the past. We will also have
 
greater effect on outcomes of,the various diabetic
 
complications that are impacted by Population Care
 
Management. Seventh, Clinical Information Systems (CIS)
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provide the means for following our defined diabetic
 
population from cradle to grave (only after a long
 
productive life). Eighth, We have developed a focus on
 
measurable outcomes; this is a crucial point upon which a
 
Continuous Quality Improvement (CQI) program will assist
 
care providers with the tools for improving care and
 
changing the processes by which care is provided. As
 
noted in the work of Peters and Davidson (1998),
 
information technology (IT) has become an indispensable
 
tool in the provision of Preventive Medicine to a growing
 
population. Besides registering and tracking a
 
population, a computerized database allows complex
 
searches for common attributes among at-risk individuals
 
and provides an ideal outreach tool. The ability to track
 
a subpopulation,permits individualization to a single
 
department, a single medical office building, or a single
 
practicing physician. Resources can be directed to assist
 
individuals or outlying medical offices that have a high
 
number of significantly at-risk patients. This concept
 
has permitted the Department of Preventive Medicine to
 
direct more care to people who have not benefited from
 
traditional, centralized care. We are finally able to
 
develop outreach programs that extend our sphere of
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influence to the furthest reaches of our Medical Service
 
Area. That satisfies the requirement that Preventive
 
Medicine go out into the: wider community to promote
 
health and prevent disease.
 
Diabetes Outcomes
 
Diabetes Mellitus (DM) is a serious, chronic disease
 
that affects over 15.7 million people (5.9% of the
 
population) in the United States. According to the
 
American Diabetes Association's Diabetes: 1996 Vital
 
Statistics (1996), approximately 800,000 people are
 
diagnosed every year and that number is considered to be
 
an epidemic in The United States. Many people are not
 
aware that they have diabetes until they develop a
 
life-threatening complication. Diabetes is the seventh
 
leading cause of death in The United States of America.
 
Diabetes contributed to 198,140 deaths in 1996 according
 
to death certificate data. For the purpose of determining
 
diabetes outcomes, we must look at the incidence of
 
complications. Cholesterol abnormalities associated with
 
diabetes contribute to a.two to four times greater risk
 
or a stroke or heart attack in the person with diabetes.
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Heart disease is present in seventy five percent (75%) of
 
all diabetes-related deaths in the United States.
 
The American Diabetes Association's web site
 
(Accessed October 16, 2001) cites diabetes as the leading
 
cause of End Stage Renal Disease (ESRD) in this country.
 
Over 51% of all people on dialysis are receiving
 
treatments due to diabetic complications. Diabetes is
 
also the number one cause of new cases of blindness in
 
The United States among people ages 20-74. Between 12,000
 
and 24,000 people lose their sight because of diabetes
 
every year. Additionally, a,person with diabetes has a
 
15-40 times greater risk of amputation compared to a
 
person without diabetes. There are more than 56,000
 
amputations performed each year among people with
 
diabetes.
 
Much attention is paid to the economic impact of
 
Diabetes Mellitus. One in seven health care dollars are
 
expended on diabetes-related disease in The United
 
States. According to the American Diabetes Association's
 
publication on diabetes costs (1996), the direct and
 
indirect costs of diabetes now exceed $100 billion per
 
year. It is one of the most, costly health problems of our
 
times.
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Improving diabetes outcomes has been the aim of many
 
scientific studies. Despite the fact that improved
 
glucose control would appear the most obvious way of
 
improving outcomes, it was not until the DCCT (Diabetes
 
Control and Complications Trial) of 1993 that the
 
dramatic degree of improvement in the outcome of Type 1
 
Diabetes could be fully demonstrated. This was followed
 
by the UKPDS (United Kingdom Prospective Diabetes Study)
 
in 1998, which demonstrated that people with Type 2
 
Diabetes had significant improvement in outcomes
 
associated with improved glucose control. The outcomes
 
studied included Retinopathy (Ocular Disease),
 
Nephropathy (Renal Disease),. Neuropathy (Neuronal
 
Disease), and Cardiovascular (Heart) disease.
 
The measurement of glucose control in every study
 
has been the determination of Hemoglobin Ale (HbAlc) as
 
well as Self-Monitoring of Blood Glucose (SMBG) values
 
recorded on home blood glucose monitors. Hemoglobin Ale
 
is an objective laboratory study that integrates three
 
months of glucose concentration in the blood. Whereas,
 
SMBG gives isolated values spread over a short period of
 
time. This is useful for day-to-day management of blood
 
glucose, but lacks the ability to give an average
 
measurement of glucose concentration. The HbAlc is used
 
as the sole measurement of glucose control in this study.
 
Diabetes outcome studies, such as Greenfield et al.
 
(1995), use surrogate markers to evaluate intermediate
 
steps toward improving the health of a defined
 
population. As previously mentioned, the Hemoglobin Ale
 
test represents the integration of average blood sugar
 
values over a 90-120 day period. This is most commonly
 
used as a marker for clinical improvement over a two to
 
three-month period of time. That data if further
 
extrapolated to clinical outcomes.
 
The frequency of performing a Retinal Screening
 
Examination in a diabetic population is a surrogate for
 
care performed at appropriate intervals in that
 
population. As we have learned from McCullough et al.,
 
(1998), the ability to coordinate care for a large group
 
is modeled by performing a yearly retinal exam on this
 
defined population. The yearly retinal examination also
 
translates to an improved quality of life, since each
 
case of early Diabetic Retinopathy detected by screening
 
lessens the chances of permanent blindness in the
 
population group being evaluated.
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Urinary MiGroalbumin (MA) testing is a surrogate
 
marker for prevention of End Stage Renal Disease (ESRD).
 
As we have learned from McCullough et al., (1998), yearly
 
urinary Microalbumin screening improves the chances of
 
early detection and treatment of Diabetic Nephropathy,
 
which eventually leads to Chronic Renal Failure (ORE),
 
The earliest stages of this process are reversible, and
 
initiation of proper treatment may delay progression in
 
later stages. This is also a marker for improved quality
 
of life, since the outcome of poor control is death or
 
dialysis treatment.
 
The performance of LDL-Cholesterol as we have
 
learned from McCullough.et al., (1998), is directly
 
related to initiation of treatment with behavioral
 
modification as well as with pharmacological treatment.
 
The higher the LDL value, the greater the risk for a
 
Myocardial Infarction (MI) or a Cerebral Vascular
 
Accident (CVA). Lowering the LDL value has the benefit of
 
improving overall health and improving quality of life.
 
This test also has the benefit.of motivating individual
 
patients toward making the lifestyle changes necessary
 
for achieving better health. In order to further improve
 
the individual health outcomes, a pharmaceutical agent is
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often added as an adjunct to the behavioral changes. The
 
appropriate attention to total health outcomes is a
 
critical factor in reducing the risk factors for serious
 
diabetic complications.
 
Clinical Practice Guidelines
 
Clinical Practice Guidelines (CPG) are
 
evidence-based recommendatiohs. that are agreed upon by a
 
panel of experts that direct a specific course of action
 
within medical decision making. These guidelines are
 
clinically useful in the determination of appropriateness
 
of ongoing medical care. Every medical field has Clinical
 
Practice Recommendations (CPR) specific to that field.
 
Wagner, Austin, and Von Korff (1996) is a proponent of
 
Clinical Practice Guidelines as a means for dealing with
 
chronic illness.
 
Diabetes guidelines, such as the Clinical Practice
 
Recommendations (2001) of the 7\merican Diabetes
 
Association, govern the type and frequency of specific
 
testing procedures. The goal is to always improve
 
clinical outcomes with respe.ct to resource utilization.
 
The frequency of performing a diabetic Retinal Screening
 
Examination is set at one-year intervals. This period of
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 time was chosen due to the slow progression of
 
sub-clinical .Diabetic Retinal disease. Intervals over one
 
year generally demonstrate a decrease in the quality of.
 
care delivered. .
 
Hemoglobin Ale testing is done at intervals that
 
would influence or change the care of an.individual
 
patient. This interval could be. from one to eight times
 
per year.
 
However, the minimum interval is set appropriately
 
at once per year. This gives much leeway toward
 
approaching the upper,end of the interval, but dropping
 
below,once a year would hinder proper care. For the
 
purpose of this study, we have evaluated Kaiser Health
 
Plan members who have had HbAlc values in the past 12
 
months and we have used this.value to. stratify,.our.
 
population for the purposes of determining the course of
 
their care.
 
HbAlc values indicate' the degree, of glucose control
 
during the prior three months. American Diabetes
 
Association .publications such.as Medical Management of
 
Type 2 Diabetes .(19.98) quote, that ."Excellent control" is
 
generally, cited as. less than 7%, "Good control" up to 8%,.
 
"Fair control" up to 9%, and."Poor control" greater than
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or, equal to 9%. The.ADA Clinical Practice Recommendation
 
is to improve HbAic as much as possible, and to address
 
HbAic values of 9% or greater as a priority group
 
requiring greater attention and treatment.
 
Urinary Microaibumin (MA) is measured at yearly
 
intervals in the early stages of Diabetic Retinal
 
disease. The clinical goal is to maintain the MA value at
 
less than 30 mcg/mg creatinine. This value is associated
 
with less risk of progressive Diabetic Nephropathy and is
 
associated with reversible changes within the renal
 
parenchyma. Treatment may consist of improved glucose
 
control and/or pharmaceutical intervention.
 
The frequency for measurement of, Low-Density
 
Lipoprotein (LDL) Cholesterol is cited in the ADA
 
Clinical Practice Recommendations (2001) as at least once
 
per year. Elevation of LDL-Cholesterol is directly
 
related to the risk of Cerebral Vascular Accident (CVA)
 
or Myocardial Infarction (MI). Clinical Practice
 
Guidelines suggest that LDL-Cholesterol be maintained at
 
less than 130 mg/dl. Many specialists now prefer to keep
 
this value at less than 100 mg/dl. The Fontana Diabetes
 
Clinic uses this value for the initiation of treatment of
 
elevated LDL-Cholesterol. The percentage of the
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population in good control of Cholesterol is an important
 
marker of potential Atherosclerotic Heart Disease within
 
a population. Cholesterol treatment helps to
 
significantly lower coronary heart disease risk. The
 
percentage of the population at-risk for elevated
 
LDL-Cholesterol that receives treatment is an important
 
measure of active medical treatment plans aimed at
 
lowering the incidence of coronary artery disease within
 
a defined population.
 
Dissemination and promotion of Clinical Practice
 
Guidelines are essential in improving the health of all
 
care-managed populations. The closer the population
 
approaches the ideal standard, the better the health
 
status of the individuals comprising the population. That
 
is why many Continuous Quality Improvement programs
 
concentrate on bringing their populations closer to the
 
ideal standard promulgated by Clinical Practice
 
Guidelines.
 
Diabetes Quality of
 
Care Measures
 
,At first. Quality of Care (QC) in any medical
 
context may be an elusive concept to quantify. How do you
 
measure the caring of the physician or the skills of the
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nurse? Therefore, measurable outcomes in improvement of
 
clinical health status become the measurable quantities.
 
The areas of diabetes care most often cited as Quality of
 
Care Measures (QCM) by national standards organizations
 
(HEDIS 2000) are: Frequency of Retinal Screening
 
Examinations, frequency of HbAlc measurements, frequency,
 
of urinary Microalbumin monitoring, and frequency of
 
LDL-Cholesterol measurements. Secondarily, the
 
improvement in HbAlc is used to assess the outcome of any
 
diabetes intervention. In addition, treatment of abnormal
 
values of urinary Microalbumin and elevated values of
 
LDL-Cholesterol are measures of the efficacy of the
 
process of delivering care. Used together, these Quality
 
of Care Measures are powerful tools in assessing the
 
impact of any clinical intervention.
 
A diabetic Retinal Screening Examination is defined
 
as a dilated eye exam performed by a licensed
 
professional within their Scope of Practice that includes
 
evaluation or interpretation of Diabetic Retinal changes..
 
A non-dilated photographic study may be used if it is
 
evaluated or assessed for Diabetic Retinal changes by a
 
Licensed professional tnained in the. evaluation or.
 
interpretation of Diabetic Retinal Photographs. The
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standard of care by national standards organizations
 
(HEDIS 2000) for performing this test is a yearly
 
examination in all diabetics, except those people having
 
Type 2 Diabetes for less than 5 years. The interpretation
 
of this Quality,of Care Measure is that any qualifying
 
exam performed within a 12-month period is indicative of
 
a higher quality of care, and any examination not
 
performed within a 12-month period is indicative of a
 
lower quality of care.
 
Urinary Microalbumin monitoring defined as a urinary
 
assay for the protein albumin, which is capable of
 
quantitative measurement within the range of 30-300
 
mcg/mg creatinine. The measurement may be performed on a
 
first morning sample, a random sample, or a timed urinary
 
sample. The value must then be recorded in a medical
 
record in order to be interpreted. The standard of care
 
by national standards organizations (HEDIS 2000) for
 
performing this test is a yearly examination. The
 
interpretation of this Quality of Care Measure is that
 
any qualifying exam performed within a 12-month period is
 
indicative of a higher quality of care. And any
 
examination not performed within a 12-month period is
 
indicative.of a lower quality of care.
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Low Density Lipoprotein (LDL) measurement is defined
 
as a quantitative assay of serum LDL that has been
 
performed at a facility that meets CLIA (Clinical
 
Laboratory Improvement Amendments) standards. This may be
 
performed as part of a fasting lipid test or a
 
non-fasting test. The value for LDL may be calculated or
 
direct. The standard of care by national standards
 
organizations (HEDIS 2000) for performing this test is a
 
yearly examination. The interpretation of this Quality of
 
Care Measure is that any qualifying exam performed within
 
a 12-month period is indicative of a higher quality of
 
care. Any examination not performed within a 12-month
 
period is indicative of a lower quality of care.
 
The frequency of HbAlc measurements is dependent
 
upon the type and severity of diabetes. Type 1 Diabetics
 
are insulin-dependent and ketosis prone. The frequency of
 
performing HbAlc in this population is cited by the
 
American Diabetes Association Clinical Practice
 
Recommendations (2001) as at least twice a year. More
 
frequent tests are done when trying to optimize glucose
 
control. Type 2 Diabetics are non-insulin dependent and
 
non-ketosis prone. Their standard for performing the
 
HbAlc measurement by national standards organizations
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(HEDIS 2000),is cited as at least once per year. The
 
interpretation of this Quality of Care Measure used by
 
this study is that any qualifying exam performed within a
 
12-month period is indicative of a higher quality of
 
care. Any examination not performed within a 12-month
 
period is indicative of a lower quality of care.
 
The improvement in HbAlc can be demonstrated in two
 
ways. First, separating the HbAlc values into quartiles
 
allows one to demonstrate changes over time among the
 
quartiles for, "Excellent", "Good", "Fair", and "Poor"
 
glucose control. The values for these quartiles are:
 
HbAlc less than 7.0% is "Excellent control", HbAlc
 
greater than or equal to 7.0% and less than 8.0% is "Good
 
control", HbAlc greater than or equal to 8.0% and less
 
than 9.0% is "Fair control", HbAlc greater than or equal
 
to 9.0% is "Poor control". Percentage changes between
 
quartiles are evidence for clinical changes in the,study
 
population.
 
The second method of demonstrating improvement in
 
HbAlc is by direct measurement of HbAlc before the
 
intercession and after the intercession. This may have
 
two phases: an early HbAlc change as well as a later
 
HbAlc change. The improvement or worsening of values can
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be evaluated for degree of change by a standard
 
statistical analysis.
 
Finally, the outcomes of a treatment intervention
 
may be measured by the number of abnormal laboratory
 
values that receive appropriate treatment. This would
 
include treatment of elevated urinary Microalbumin values
 
with an Angiotensin Converting Enzyme (ACE) inhibitor or
 
other equivalent treatment, or treatment of elevated
 
LDL-Cholesterol with a "statin" lipid lowering drug or
 
other equivalent treatment. The quality of care standard
 
is to treat the abnormal value. The Interpretation of
 
this Quality of Care Measure is that any prescription for
 
an appropriate drug within a 12-month period is
 
indicative of a higher quality of care, and the absence
 
of any prescription for an appropriate drug within a
 
12-month period is indicative of a lower quality of care.
 
Diabetes Models of Care
 
The models of care that are used for providing
 
medical attention to a diabetic individual or to a
 
defined diabetic population vary widely. According to the
 
study by Hayes and Harries (1984), they may include doing
 
nothing (a minimalist approach) or providing one-to-one
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physician contact on a daily basis (the private hired
 
physician approach). The approach used to monitor or
 
manage a large population must include appropriate
 
resource allocation as well as information management.
 
Physician extenders become mandatory with larger
 
populations.
 
The role of the Diabetes Nurse Educator has grown
 
over the past ten years as described by Wagner (1998) in
 
the Annals of Internal Medicine. Initially, a Registered
 
Nurse was member of the health care team whose role was
 
to follow specific physician orders to administer
 
medications, provide palliative care, and basic personal
 
hygiene, as well as educate and console. Very little
 
deviation was allowed from this traditional model of care
 
in nursing. .
 
However, over time, the Outpatient Clinical Nurse
 
Educator was given protocols that gave this individual
 
the ability to act on the doctor's behalf as an
 
interpreter of clinical protocols for one individual
 
patient. At this stage, the Registered Nurse could assist
 
a diabetic patient in increasing his/her insulin dosage
 
by a small amount only by referring to a specific written
 
instruction written by a physician for this patient. From
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this early beginning, the more complex protocols of today
 
developed.
 
As other medications became available for the
 
treatment of diabetes, the existing nursing protocols
 
became more complex Policies and Procedures that
 
permitted changes in classes of drugs as well as
 
permitted adding new drugs to an existing regimen all the
 
while being closely mentored by a physician who remained
 
responsible for prescribing the individual medications.
 
The more complex medical regimens lead, to more
 
sophisticated monitoring of drug reactions. The nurses
 
were given additional Policies and Procedures that
 
permitted them to stop medications, order appropriate
 
blood tests, then restart the same medication if the
 
testing was negative.
 
This expanded role, of the clinical diabetes
 
practitioner has lead to the development of the Certified
 
Diabetes Educator (ODE) certification. Skill in assessing
 
difficult situations as well as recognizing clinical
 
scenario became a foundation of the job of Clinical
 
Diabetes Nurse Educator. These nurses assess compliance,
 
determine the degree of diabetes control, change
 
treatment parameters, and follow up on complications and
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problems that fall within their clinical nursing Scope of
 
Practice.
 
The present model of care for our diabetic members
 
at the Kaiser Permanente Medical Center in Fontana had
 
evolved to the point that Registered Nurses and
 
Registered Dietitians teach ail of the diabetes classes
 
in our clinic. The Nurse Care Manager triages phone calls
 
and manages medication changes by phone with approval of
 
the Physician mentor. The Nurse Care Manager reviews
 
abnormal laboratory values and discusses medication
 
changes with the Diabetes Specialist. The Clinical
 
Diabetes Nurses interact individually with their patients
 
and teach the most effective ways of maintaining
 
excellent glucose control. They also start new diabetes
 
medications based upon strict diabetes management
 
protocols.
 
Primary Care Physicians have indicated that they
 
would prefer to have the Fontana Diabetes Clinic
 
(together with Dr. Hess, the Endocrinologist) manage
 
their diabetic patients. The clinic has been able to
 
order appropriate laboratory tests on active patients and
 
monitor the results of those tests. Abnormal values are
 
communicated back to the primary physician for treatment
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 or further'study. Diabetes mediGatiohs are optimized, and
 
glucose■control improved under strict protocols. 
Folldw-up appointments, are made at the Fontana Medical 
Center in drder to maximize the use of the nurses' time. 
Eventually,, it .became; evident that the Kaiser Health 
Plan.members that did not improve over time were the 
members who did not. show up.for appointments and did not 
respond to phone calls and letters. Many of these.members 
were assigned to physicians in the outlying medical 
offices as far away as Pomona and Victorville, . 
California. There had to be a way;to .place a highly 
trained Diabetes .Nurse Educator in the outlying medical 
offices such that.the quality of care issue brought to 
light by having poorly controlled diabetic members could 
be addressed in art effective manner. This .study describes 
one .such model of care and atteinpts to define the 
characteristics that make; this raodel. o.f care so 
effective. \'y . 
Care Management 
; Care Management has been described by the SCPMG ; 
Diabetes .Qutcome .Report .(2000.) as ."Improving the ■health) 
of a population ..:one member; at. a time. 'c It applies the 
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knowledge and science of.Public.Health to a chronic
 
disease arena. The critical cteps asv stated in the
 
article by Gurnee and Da Silva (1997) for applying Care .
 
Management to'a large population include 1) Identifying
 
the at-risk population, 2) Stratifying:the. population by
 
acuity, 3) .Tracking and monitoring interventions Upon the
 
population, .4),Developing: and implementing Clinical
 
Practice Guidelines, 5): Creating new, proactive , ,
 
interventions (both outreach and inreach) .6)
 
Coordinating care among various individuals,. 7). Measuring
 
outcomes,, and 8) Continuously improving the quality of
 
care
 
Defining an at-risk population is.bne of the first
 
steps in Care Management. .For diabetes, this is
 
accomplished by.the Southern California Permanent
 
Diabetes Registry Database. Fontana patients are a Subset
 
of that database, and all efforts are, measured thrpugh
 
that database. National quality,standard's for diabetes
 
care, such, as, HEDIS (2;Q00) are tracked through,this
 
database as well as through others., , , ,
 
Risk Stratification is a method by which the sickest
 
patients or the most'dt-risk.:patients, are identified and
 
categorized.by .their likelihodd of' developing significant
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±llne:sS;,o requiring, sigriifieant. interventi This is
 
most . often,;.performed by examining ,,,the medical; record and
 
developing an algorithra,for ranking'individual^clinical ,
 
charact.eristics, such as, labbratdry^r ,:.frequency of
 
, hospitalizat'lon,: and concurrent Illnesses. A .value is 1
 
then applied to this;rahkihg, thus allbwing cdmparisdn
 
among the members;,of the at-risk populatidns^^ , .
 
.. . Tracking ihtervehtions that:;axe Subsequently . ;
 
performed upon the..population then becomes the focus of.
 
the Gare Manager.:;This requires':access to quantifiable
 
clinical data'that impaGts .the qverall health of the
 
study population. The .goal is- to improve:the overall :
 
health and move:as. many: peqple as possible from high risk
 
•to lower risk categories. ...
 
Clinical practice guidelines (CP.G)' are the: tools, for.
 
moving a large ciiaical pppulati.On . f.rpro higher v to lower,
 
risk. The : Physiciaps . and Care Managers.'bob^ try to
 
deliver the highest quality :ca.fe to ..those: people they '
 
serve.. Having a stahdard by w measure;.that care is .
 
critical:-to day-to-day tfe.atment, as well as to improving
 
future:treatment.:
 
Outreach .is an . important . component of . care . i ; .
 
management. This requires .identific:.ationq.f.people at
 
need for extra care. Outreach may take the form of a
 
letter or phone call. Newsletters and flyers are used to
 
address large numbers of at-risk individuals. Whatever
 
the means of communication, the goal is to provide better
 
diabetes care and, therefore, improve clinical outcomes.
 
Computers, as proposed by Peters and Davidson (1998),
 
have improved outreach programs significantly. Targeting
 
a population identified in the outreach process allows
 
intervention with the people at highest risk. The method
 
or encounter may be done one-to-one, small group, large
 
group, or classroom. Contact by phone. E-mail, or fax may
 
be sufficient in some cases.
 
Inreach involves the same technique applied to
 
at-risk individuals already, involved in an intervention
 
program. Some of their needs may be already met by their
 
medical care system; but there are always gaps in care
 
that must be identified, addressed, and treated.
 
Following the initial Care Manager contact, there
 
must be a way to identify the patient receiving care
 
management in order to affect long-term survival, such as
 
in the study by Verlato, Muggeo, Bonora, Corbellini,
 
Bressan, and de Marco, (1996). This assists the follow up
 
and patient tracking process. This also makes information
 
available to other care managers in order to avoid
 
duplication of effort. This ability to track a patient
 
makes possible the evaluation of the care managing
 
process and coordinate care among various providers.
 
Care Managers use tools to remind patients to
 
perform required laboratory testing. These tools improve
 
the delivery of care and facilitate compliance with
 
national healthcare standards such as HEDIS (2000). The
 
Clinical Information Systems (CIS) makes it possible to
 
access many forms of data simultaneously, including
 
pharmacy data, laboratory data, demographic data, and
 
hospitalization data. This information set ultimately
 
becomes part of the reporting set to employer groups and
 
the National Committee for Quality Assurance.
 
Finally, the techniques of Continuous Quality
 
Improvement (CQI) have crucial bearing upon the field of
 
medical care. The work of Dalzell (1998) shows that
 
feedback of data to care providers becomes essential.
 
Giving providers a yardstick against which they may
 
measure their own efforts provides a means for striving
 
to improve the standards of care. Those who exceed the
 
standard should be recognized and rewarded for their
 
efforts. Those who under-perform the standard have the
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opportunity of learning from their'.pee^^ Gver, time;, .as ­
observed by MacKinnon, (1990), t:b^^ of the
 
pOpulatioh will improve tp bh■optimum point possible with 
existing resources. Study :df ,thd popuiation also promises 
to demonsbfate how to best utilize those, resources. The 
best measure of. quality imprbvement is a healthy patient. 
ClinicaT Tnformatibn Systems ^ 
.Clinical:Information Systems (CIS) . serve several, 
purposes. First, they must access legacy, systems that . . 
store individual 'demographic data, clinical..medical data, 
laboratory data,.ihospitalization data, and intervention 
data. Second, they, must link the databases served.by the 
legacy systems in order to permit "data mining" for 
clinical purposes. Third, these linked systems permit the 
formation of data registries that hold the key to 
identifying at-ri.sk .populations. Fourth, the at-risk 
population may be. stratified through the use of clinical 
data, and bhis data used as an' outreach, as well as . 
inreach, information tool. Fifth, pa.tient..tracking and 
monitoring involves a separate tool, that has been brought 
down to the provider level. Sixth, a measurement and 
communication tool has to be .developed, in order to 
disseminate Clinical Quality Information to the
 
appropriate medical provider.
 
Legacy systems, such as those described by Shea,
 
Du Mouchel, and Bahamonde (1996), often share the
 
attributes of incompatibility and lack of data
 
standardization. Assuring that the data obtained from
 
these systems matches the needs of the clinical care
 
provider is a difficult undertaking. This is due to the
 
fact that one is extracting data not initially intended
 
for this ultimate purpose. For example, hospitalization
 
data has traditionally been collected for use by the
 
hospital. Obtaining this data often requires a thorough
 
understand of five to ten separate data formats and
 
programming languages.
 
Linking incompatible databases often requires
 
setting up yet another database that stores merged data.
 
This requires frequent updating of information and may
 
introduce a source of error. This requires that data be
 
analyzed before releasing it for use by the care
 
provider.
 
Data registries, such as those of Baker et al.
 
(2001) at the MayoClinic, are the result of analyzing
 
clinical date on an identified population. The population
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can be categorized by the presence or absence of a
 
clinical condition, such as diabetes. This is done
 
through the use of identifiable characteristics, such as
 
blood glucose values. These clinical data registries form
 
the basis of all monitoring, tracking, and interventions.
 
This data is frequently used by National Quality of Care
 
organizations, purchaser groups, as well as by the
 
providers in the medical organization.
 
Risk stratification identifies the characteristics
 
of group members at-risk for significant mobility or
 
mortality. This helps to provide a continuum over which
 
the entire population may be placed. These data form the
 
basis of outreach and inreach initiatives. This also
 
allows for the placement of scarce resources where they
 
will have the most impact on the population.
 
Care providers will see only a portion of the
 
overall data as it applies to their individual patient
 
population. The ability to track the improvements in
 
health of any individual holds the potential to raise the
 
standard of health of the entire population. Each
 
provider can monitor normal and abnormal laboratory
 
values on his/her patients and subsequently provide an
 
intervention that will move their patient closer to
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optimum health status. Using a patient tracking .system
 
acts as a behavior modifier for the provider and as a
 
motivator to continuously improve cafe.
 
Finally, the ontcomes of this clinical intervention
 
must be .collected, analyzed, and reported. The provider
 
must be able to see the, fesult of his/her work. The Care
 
Managers, such as those in;the Weinberger et al., (1995.)
 
study must be able tO; assess .the efficiency,of.their
 
interventions with the populations. The clinical quality
 
managers, must be able to spot, tends, that, would detract
 
from care and that would improve care in used more
 
widely. .Patients should witness their own health
 
improvements, and the purchasers of health ; care .should ,
 
see that their health care premiums are well,spent. The
 
national quality standards organizations, also: hope to
 
;identify best practices among 'health,, care organizations
 
for the purpose of disseminating the most useful health
 
care practice models,. ,
 
, , Tracking Care Impfbyement
 
Quantifiable outcomes arq necessary for evaluating
 
any medical interventiont These outcomes may be measured
 
by frequency of hospitalization Or mortality. However,
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these are considered to be very long-term outcomes.
 
Intermediate outcomes need to be developed in order to
 
assess progress towards long-term outcomes. That is why
 
surrogate outcomes are used to model the health status of
 
an at-risk population group.
 
Hemoglobin Ale is a measure of glucose control over
 
a three months period of time. However, it is used to
 
model the health of a diabetic population since it is
 
directly correlated to the incidence of chronic diabetic
 
complications. In the DCCT trial of 1993, the'incidence
 
of new Diabetic Retinopathy was reduced by 76%. The
 
incidence of new Diabetic Nephropathy, was reached by 50%,
 
and new Diabetic Neuropathy was reduced by 60% in a
 
population composed of Type 1 Diabetics. The UKPDS study
 
of 1998 showed that improved glucose control reduced the
 
risk of requiring Retinal Photocoagulation by 25%, and
 
the risk of Myocardial Infarction (MI) by 16% in a Type 2
 
Diabetic population.,This has significant clinical impact
 
upon the entire diabetic population and is often cited as
 
a reason to promote Diabetes Care Management.
 
Performing the Diabetic Retinal Screening
 
Examination at regular intervals permits the detection of
 
treatable stages of Diabetic Retinopathy. Early treatment
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will generally delay the progression to blindness that
 
results from this,disease. Therefore, it is used to
 
assess the degree of care in a diabetic population. In
 
addition to lessening the risk of permanent blindness,
 
the documented Retinal Screening Exam permits outside
 
reviewers, such as NCQA, an assessment tool in
 
documenting the care processes of a health care
 
organization.
 
Urinary Microalbumin is a critical tool for
 
assessing the presence of Diabetic Nephropathy in a
 
diabetic population. It also tracks the progression of
 
this disease over time. Once proper treatment is
 
initiated for Diabetic Nephropathy, the urinary
 
Microalbumin is used to assess the efficacy Of the
 
treatment intervention. Lack of monitoring of this marker
 
for chronic complications demonstrates poor surveillance .
 
techniques for an at-risk population. Producing a list of
 
untested individuals permits a Primary Care Physician .
 
(POP) or Care Manager (CM) the means for scheduling and
 
performing the proper testing. This list also forms the
 
basis, of one arm of the outreach program by identifying
 
under-served individuals in-the population.
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Monitoring.LDL-Cholesterol is a much more global
 
marker for overall health outcomes since over 75% of
 
people with diabetes ultimately expire from 
atherosclerotic disease complications. Improvement in ■ 
LDL-Cholesterol values tracks the improvement in 
cardiovascular risk. The use of;pharmaceutical 
interventions in this population promises to 
significantly impact the mbrtality figures for Coronary 
Artery Disease,in..this population, Following up on ; 
treatment is one method by which the care, manager impacts 
the overall health of the population that is being 
followed. The importance, of tracking care improvement is 
essential to the, mission of a preventive care " 
organization. 
Compliance/Adherence
 
Adherence to any medical regimen,is important in
 
determining the outcome of treatment. In Gurnee and
 
Da. Silva-s 19.97 article on constructing disease
 
management prbgrams:,, the. regimen that is adhered to. the
 
best will, have the .greatest effect on the health of the
 
population under study. Several factors that determine
 
adherence are:. simplicity, clarity, relevance,
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accessibility, and reinforcement Other factors include:
 
age, maturity, and educational level. However, these
 
factors are less modifiable than those previously
 
mentioned.
 
Education is necessary to elicit compliance when the
 
tasks involved are either complex or do not show obvious
 
connection to readily perceptible consequences. Diabetes
 
self-care is not particularly complex, as Peters and
 
Davidson discuss in their 1995 article. However, the
 
general population of the United States of America
 
continues to move further away from good health
 
principles in its diet and activity regimen. We are
 
becoming grossly overweight and in poor physical
 
condition. Efforts must be undertaken to prevent this
 
decline in our community health. Studies published by the
 
American Diabetes Association, referred to in Diabetes
 
Mellitus (1999) have shown the connection between poor
 
eating habits, increasing weight, decreasing activity,
 
and the onset of chronic conditions such as Diabetes
 
Mellitus. Many people with this diagnosis are in denial
 
of the seriousness of their disease. This is evidenced by
 
the increased profitability of herbal remedies that
 
purport to improve, and even cure hypertension, diabetes,
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and heart disease. However, the failure of alternative
 
treatment eventually leads to.complications and even
 
death. This Is an Inescapable truth that needs repeating.
 
The explanation of simple concepts Is Important but
 
time-consuming. Many Physicians lack the time needed to
 
adequately address the Issues and educational needs of
 
their diabetic patients. That Is. why diabetes educators,
 
such as In the study by Weinberger et al. (1995), are a
 
necessary part of the diabetes treatment team. Patients
 
tend to comply with what they understand best. The
 
simplest explanation Is. often considered the best.
 
Bringing the message down, to the proper grade level often
 
makes It more accessible to the listener. Language Is
 
another barrier to learning that must be overcome by a
 
skilled Instructor. That Is a compelling reason to have a
 
diverse staff working In the Department of Preventive
 
Medicine.
 
Making, this topic relevant Is an Important tool In
 
achieving adherence to a self-care regimen. Everyone has
 
a unique background and comes from a unique environment.
 
The ability to address a group of people and
 
Individualize the experience for each person Is a
 
considerable task. Diabetes educators are trained to
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facilitate learning by finding common experiences in a '
 
group of individuals and extracting relevant information
 
that assists the learning process for the entire group.
 
The location at which the care is provided should be
 
convenient to the individuals being,treated. The further
 
away the facilities of care the: more, li.kely that.members
 
of the target population will be missed by the planned
 
intervention... The clinic where the member has a Primary
 
Care Physician and where the. member obtains the majority
 
of his/her care is the ideal Ipcation for a highly
 
successful intervention. ■ 
Repetition.aids learning and provides positive
 
reinforcement. Patients appreciate the concern
 
demonstrated by a return phone call. This simple
 
intervention permits the care manager to. keep closer tabs,
 
on the individuals that are followed and address any
 
concerns that could'have otherwise hindered appropriate .
 
■care .. ■ ■'/ ■;.... : ■ , ­
Authority Figures in 
Medical Studies 
. Studies completed in the 196.0' s by Stanley Milgram 
(Obedience to A.uthority, 1974) demonstrate that people 
are prone to obey those in authority even under extreme 
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circumstances. This is evident when one experiences the
 
"white coat mystique" upon entering the doctor's offices.
 
Physicians have long been considered authority figures by
 
the public and by those that work alongside them. The
 
public is much more likely, to obey a medical
 
recommendation if it is reinforced by a "Doctor" than if
 
it were recommended by another ancillary medical
 
personnel. This effect is perceptible even when actors
 
portray physicians on television commercials.
 
The use of a Physician in emphasizing the need for a
 
lifestyle change can make the difference between
 
adherence and non-adherence. This effect is amplified if
 
the Physician , is the same Primary Care Provider who has
 
already established a relationship with this patient.
 
The Physician as authority figure also provides a
 
source for enforcing logical consequences with the
 
patient. Many people will cooperate with a treatment plan
 
so that they do not disappoint their family doctor. The
 
physical presence of this Physician in the examination
 
room emphasizes the importance of the issues addressed by
 
the treating Clinical Nurse Educator. People perceive a
 
greater value in an appointment in which their own Doctor
 
has made an appearance.
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The presence of a Physician in a group setting makes
 
the patient more confident that the information being
 
given is medically correct. There is now a central figure
 
that can take responsibility for the care being provided
 
to the members of the group. The Physician is seen as the
 
coordinator and ultimate provider of any intervention
 
made during this appointment, even if the intervention
 
was made at the recommendation of the Clinical Nurse
 
Educator.
 
Time and Place Utility
 
As was previously stated, the location for
 
delivering care may be determining factor between
 
adherence and non-adherence. Any study of care delivery
 
and models of care must look at the most appropriate
 
location for that care, as was reported by Hayes in 1984.
 
If traditional care was held in a centralized location,
 
then non-traditional care must look elsewhere if access
 
to care is a critical factor. The location may be within
 
a few miles of the home itself. House calls may be done
 
in person, over the phone, or over the World Wide Web.
 
There does not seem to be any means of communication that
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 is considered to be too convenient. Both time and place
 
must be considered in planning an intervention.
 
In a population that may be hampered by
 
transportation-related issues, both time and place
 
utility come up as critical factors in providing
 
appropriate care. If the initial appointment was
 
successful in obtaining the cooperation of the patient in
 
his/her own care, then the follow-up contact has to be
 
equally as appropriate in time and place. This is the
 
obvious scenario for phone contact. The patient has
 
already encountered the Clinical Nurse Educator in the
 
clinic setting with, their Primary Care Doctor as the
 
initiator. A relationship of trust has been developed
 
between the patient and the nurse. Now, reinforcement of
 
the educational objectives may be accomplished at one'S;
 
leisure by phone, and the nurse is free to suggest other
 
changes to follow the successful changes made previously.
 
This is the ultimate goal of the Care Manager, that the
 
patient be the main focus of the care management program
 
and that the process of Care Management be the transfer
 
of information by means of telecommunications. This
 
allows the Care Manager sufficient time to assist many
 
individuals in a single workday.
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Group Dynamics
 
The manner in which care is delivered is as
 
important as the location of its delivery. The Group
 
Medication Model is successful not only due to its
 
ability to reach more people, but. due to its ability to
 
facilitate interpersonal interaction. People are social
 
beings. This concept was explored by Ho et al., (1997)
 
when examining the model of care delivery at the
 
centralized diabetes clinic. Their behavior is changed
 
when they go out in public. Opinions are often formed by
 
group norms. The use of a group for the purposes of
 
teaching lifestyle changes goes back to prior to recorded
 
history. The dynamics of group interaction plays a
 
pivotal role in shaping human behavior.
 
People frequently assume well-defined roles when
 
interacting as a group. One or more individuals are seen
 
as leading the group. Others are seen as active
 
participants, others as passive participants. If the
 
leader has sufficient skills then most other participants
 
should see themselves as active group members. Well-run
 
groups participate fully in the educational process by
 
asking questions and assisting others in the group to
 
understand the responses. Ideally a diverse group will
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have answers to Frequently Asked Questions among the
 
participants. 'People are naturally curious as to the.
 
insights of other group members. This allows those
 
members-who ask the questions to see. that others likely
 
share their opinions...When . some individuals in a group
 
show enthusiasm for the message being taught, the passive
 
participants, tend to show consensus; with the group.norm. . .
 
People that would otherwise, be slow in accepting a
 
message may quickly accept the message., in order to be
 
perceived as part of a.group. Therefore,. group messages
 
tend to be effective if the majority of the group members
 
embrace,the message.
 
Group appointments also tend to discourage ,
 
disruptive behavior. .Disruptive group members can always
 
be invited to an individual appointment or be asked to
 
discuss their concerns after .the session has ended. The
 
group facilitator must be well versed in group teaching
 
skills. That is why sufficient time must be given to the
 
facilitator of the group for developing rapport with the ;
 
multiple group members.
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CHAPTER THREE
 
REPORTING OF FINDINGS
 
Restatement of the Problem
 
For many years. Primary Care Physicians have had
 
little time to spend instructing their own patients on
 
the correct manner for taking care of one's diabetes.
 
This shortened period of time meant, that some of the
 
complex needs of patients with diabetes were not being
 
met in brief problem-oriented office visits,. This led to
 
the creation of specialized diabetes clinics, such as
 
those described by Ho et , al., (1997) that brought
 
together the personnel and resources needed to, meet the
 
needs of those diabetic patients. This exact,model for a
 
centralized diabetes care clinic exists presently in the
 
Fontana Service Area,of the Kaiser Permanente Health Care
 
System.
 
However, this trend raised concerns among Primary
 
Care Practitioners in Britain, with the publication of
 
studies by Farmer (1990), Koperski (1992), and Pringle
 
Ward, and Chilvers (1993), where a Primary,Care Model
 
exists within a socialized medical structure. There was
 
sufficient impetus to create a series of chronic disease
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 "mini clinics" that attempt-ed to iricorporatethe teachihg
 
.and specialized care of the centralized diabetes clinic
 
model into the realm and domain of"the: Primary .Ca.re :
 
Provider.
 
■ These "mini clinics" were, comprised of patients .all \ 
with a specific disease entity into a specially designed 
visit with a team approach to.care. These clinics met at. 
regular intervals and were shown to impiroye glycemic 
control and reduce hospitalizations/ ­
The present study incorporates yet another care
 
design that was not feasible 15 years ago. The Diabetes
 
Nurse Care Manager has been trained to evaluate and
 
assess the physical, social, and medical needs of
 
individual patients as well as at-risk diabetic
 
populations. Through the use of computerized case-finding
 
tools and electronic database.management techniques, the
 
Diabetes Nurse Care Manager identifies, arid then follows,
 
an at-risk population for trends in each individual's
 
care. This job entails scheduling offide;visits,
 
laboratory testing, ophthalmology visits, and monitoring
 
changes,in glucose control, in much the same way as the
 
study nurses acted in Wagner's study published April of.
 
this year. The nurse intervenes with letters, office
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visits, phone calls. The Diabetes Nurse follows a strict
 
protocol for changing medication dosages as well as for
 
adding or starting new diabetic medications. The
 
frequency of this intervention depends upon the severity
 
of the illness. The recording of clinical data, as well
 
as the analysis of that data is an important part of the
 
role of the Care Manager.. . This Quality of Care (QC) data
 
allows each Diabetes Nurse Care Manager to determine the
 
impact he/she had on the diabetes population being
 
followed. This study is the report of the first two (2)
 
Diabetes Primary Care Group Visit Model clinics held in
 
Colton, California and Victorville, California during the
 
year 2001.
 
Scope and Limitations
 
This study is being conducted entirely with members
 
of the Kaiser Health Plan that are managed by the
 
Southern California Permanente Medical Group (SCPMG).
 
Founded in 1945, Kaiser Permanente is the nation's
 
largest nonprofit health plan serving 8.2 million
 
members. There are over 3 million lives (3,052,644)
 
covered by the Kaiser-Permanente Health Care System in
 
Southern California as stated on the Kaiser-Permanente
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Intranet site (accessed September 27, 2001). In the
 
Fontana Medical Service Area there are approximately
 
371,000 active members. Of this number there are 15,482
 
individuals (4.2 percent) identified as having Diabetes
 
Mellitus. A nonrandomized longitudinal study was
 
conducted on a subset of this population being followed
 
in the Outlying Medical Offices of Colton and Victorville
 
in the Fontana Medical Service Area.
 
All participants are over 18 years of age and have
 
been Kaiser Health Plan members continuously for one year
 
preceding enrollment in this study. The patients being
 
studied had been chosen through the use of a computerized
 
relational database tool (POINT) that derives diabetes
 
data from Laboratory, Pharmacy, Hospital, Emergency
 
Department, Outpatient Department, and Demographic
 
Administrative databases to form an automated Diabetes
 
Registry. The principle criterion for inclusion in this
 
study was an HbAlc value of 8.9 and greater. Lists of the
 
at-risk diabetic population were created for each
 
participating physician in the Outlying Medical Offices
 
listed above. The nurses created lists only for those
 
physicians that wished to participate in a
 
shared-practice group visit model of care in which a
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 Diabetes Nurse Care Manager helped that Physician manage
 
a higher-risk subset of his/her diabetic population.
 
There is insufficient evidence to note whether
 
cooperative physicians have .better or worse outcomes with:
 
their diabetic patients.. Therefore, this• population must
 
be considered to be a nonrandomized'sample. .
 
/. The.patients that participated in this
 
shared-practiGe model had. agreed to come to' at least one
 
physician visit during which the Diabetes Nurse Care
 
Manager explained his/her role and limitations. He/she :
 
would also discuss general .Diabetes Care .Guidelines with
 
the participating members ... This would lead to some . degree
 
of bias towards ambulatdry- patients or pa;tients with
 
available., transpoxtatloh ... Patiphts family or ,
 
community resources tend to.!'do^ better in their diabetes
 
care than,do those: patients, wholdo!/not have th
 
resources./ /■/ ; . ■ ./ !' ; ■ 
The model,of care.described in this study is;in . 
addition to the presently .available centralized model of : 
care utilized in the Pontana Medical Center Diabetes Care 
Program. There are two /:2) Physicians/ seven . (7) 
. Registered Nurse: Diabetes Educators, one (1) .Registered . . 
Nurse Practitioner:, six . (6). Registered Dietician Health. 
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Educators, four (4). Health Education Specialists/ two,. ,(2)
 
,Ph,D. .Public Health .(Dpctors of Health Scie.nce,,: ,0:ne^^^
 
pending dissertation)/land one Department.Adinihi.strator;
 
Ph/D. Public Health currently full. dr.;.p^^^^ time/;.All , ;
 
Kaiser Health plan.inembe.rs may access .'the Diabetes .Care
 
Clinic.; by self-referral,drv provider, ref.erral,. The
 
combination of classes., groups, and individual
 
appointments 'provided at .the Fontana Medical.VCenter would
 
.be the alternate care provided to : those who chose not to 
participate .in,: the Istudy. All nonstudy participants are . 
derived . from .the/ diabetic population at large in the 
Fontana Service Area ' . - . - ^ ■/' ;■ 
.Finally, ,the .dhoice of selecting a range, of, .; . 
Hemoglobin Ale from 8.. 9 and above to represent a . 
higher-risk group Was ..arbitrarily "based upon HEDIS 2000 ; 
measures demonstrating poor vs. acceptable control for, , 
diabetic Health Plan members whose Hemoglobin . .Ale was ; 
at-risk for exceeding 9.5%. 
Sampling Plan 
A Care Management tool (POINT) developed by. Pharmacy 
Operations within Kaiser-Permanente was used to develop . 
the Intervention Population that: was followed by the \ 
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 Diabetes Nurse Gare Manager. This database system allows
 
queries to be undertaken;on a Southern California
 
Regioh-wide Diabetes Registiy. The Medical Center's. and
 
the individual Physician's. diabetes panel were easily
 
identified, using this;.tbo.l A list of those.patients > 18
 
.years of age with a .Herhoglobin .Ale .>■ 8 .9% Were presented 
to their Primary .Care,PhysiGian .for approval. Each 
Physician, was: given the pppprtunity. to ex.clude: patients 
due to .unsuitability: to a group .format. If approved, 
these patients were contacted by phone and/or letter 
asking them, to participate in a two-hour doctor's visit 
in which several Individuals will address,their diabetes 
questions. It is at this point that some individuals were 
excluded by refusal, .educational barrier, or language 
barrier . . Approximately 45%. . .of" all invit.ed. patients never 
attended a single.iclinic session. These..individuals were; 
offered one-to-one counseling and management by a . 
culturally appropriate Physician.or NurSe Educator. 
■ The ,number of participants attending a group visit 
appointment was often. 8-12 patients. When the group:of 
selected members met with the Diabetes Nurse Care Manager 
and .their Primary Physician, they received a 
psychoeducational intervention followed by a review of 
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their medical treatment and pertinent laboratory testing.
 
Those patients that needed any changes in medication got
 
those changes made on the spot. Pertinent laboratory
 
tests were ordered and performed the same day. The
 
Diabetes Nurse Care Manager was responsible for informing
 
his/her patients of the results of their tests and
 
maintaining phone and letter contact with his/her patient
 
population for at least one-year. However, for the
 
purpose of this study, each patient population was
 
studied for six months prior to their intervention as
 
well as six months after their intervention.
 
The data collected on each patient by each nurse at
 
every intervention was recorded in a clinical diabetes
 
database that served as an Electronic Health Record
 
(EHR). Further data for this study were available on
 
legacy mainframe computers that compile administrative
 
data, as well as demographic, laboratory, pharmacy, and
 
hospitalization data for the members of the Kaiser Health
 
Plan.
 
This has been an ongoing project of the Preventive
 
Medicine Department in Fontana even before the initiation
 
of the present study. This study was a nonrandomized,
 
longitudinal, statistical monitoring study that falls
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into the category of causal-comparative research design.
 
Therefore the intervention group was not subject to
 
investigator bias because this investigator had no input,
 
into patient selection.
 
Methods and Procedures
 
The population already discussed has been followed
 
for improvement in their Surrogate Care Parameters
 
(Frequency of performing HbAlc, MA, and LDL-Cholesterol)
 
as a measure of quality of care. During the course of the
 
study any changes in these.parameters have been
 
attributed to the Nurse Care Manager intervention as
 
these patients were receiving routine care prior to their
 
intervention. In addition, all participants have been
 
continuously enrolled in the Kaiser Health Plan for the
 
one-year preceding this study thus allowing direct
 
comparisons to take place from within as well as from
 
without this study population.
 
This data has been extracted from the Electronic
 
Health Record (FileMaker Pro 4.0() used by the Diabetes
 
Nurse Care Manager for recording all routine
 
interventions in the Preventive Medicine Department
 
including those interventions performed on the study
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 population. The study group used a specific code for the
 
purpose of separate: identification. However, no Care
 
Manager was instructed to give either better or worse
 
care to this group.. The Standard of Care was to be the
 
same degree of excellence given all our patients. This
 
also allowed direct comparisons to take place from, within
 
as well as from without this, study population. ,
 
Other sources of data, include, the POINT Care
 
Management System, the legacy demographic; and laboratory
 
databases, as well as the Diabetes Outcome Reports.from
 
the Southern California Permanente Medical Group. The
 
data was analyzed with. Excel( functions and analysis
 
tools as well as,;,with Stat Package for the Social
 
Sciences( (SPSS)., These also formed the basis for the
 
charts and graphs used within this study.
 
„ Data Analysis , ,
 
In order to demonstrate statistically significant
 
changes at baseline in Hemoglobih Ale frequency, ,Urinary
 
Microalbumin frequency, LDL-Cholesterol frequency/as
 
well as, changes in HbAlc values; w,e report simple means
 
or proportions, with,P-values from an unadjusted mixed
 
model analysis to compare the control and intervention
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groups. To control for the patient's expected likelihood
 
of receiving the routine cafe and screening tests, these
 
patients are being compared to their own pfevious lab
 
values, prior to the Care Management intefventiop.
 
Additional: data was collected on the frequency .of , ­
performing yearly Diabetic Retinal: Screening
 
Examinations. This data was -compared to regional averages
 
within the - Kaiser-Permanente Health Ca.re system as well ,
 
as to national averages for. -other health care plans. That
 
data is avaiiable thfpugh the National Committee for . .
 
Quality Assurance website (HEDIS, 2000)".. .
 
-Data on the . presence of abnormal Urinary) ; ■ 
Microalbumin and abnormal,LDL-Cholesterol were:, bbtained \
 
through.the POINT Care Management tool. This data tool
 
also prdvidad.infofmation on whether: each:patient,had;
 
received pha.rmaceutic.aT treatmen.t fof.^h.isVo^f^^^^ her clinical
 
, laboratofy . abnormality:.'That' data was also compared with .
 
other Kaiser fegions outside, of Southern California by
 
the 'Use pf the same .statistical.methodsh
 
Results ■ 
There were, a total, of ,91 participants in. the study 
that attended the :two-hour session with the 'Diabetes 
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Nurse Care Manager and their Primary Care Physician. This
 
population consisted of 46 males and 45 females. There
 
were 55 participants from the High Desert Medical Office
 
in Victorville and 36 participants from the Colton
 
Medical Offices. Their average age was 56.2 + 11.2 years.
 
The range was from 33 to 84 years of age. No participants
 
were lost due to mortality. When examined for the
 
co-morbidities of Congestive Heart Failure, Renal
 
Disease, or Coronary Artery Disease; there were fourteen
 
(14) participants with one co-morbidity, three (3)
 
participants with two co-morbidities, and one (1)
 
participant with three co-morbidities.
 
Table 1 shows the outcomes of the care intervention
 
at three and six months. The average Hemoglobin Ale at
 
baseline was 10.34 + 1.33%. This illustrates the poor
 
control of the target population. The average Hemoglobin
 
Ale at three months post intervention was 8.34 + 1.61%.
 
This illustrates an improvement from the baseline value
 
in the short term. The average Hemoglobin Ale at six
 
months post intervention was 8.09 + 1.52%. This value
 
illustrates improvement from the baseline in the longer
 
term.
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For illustrating compliance/adherence the frequency
 
of performing a Hemoglobin Ale during the study period
 
was evaluated. This value was 86.81% compared with a
 
Southern California Regional average of 81.25% during a
 
similar period. Similar data from the National Committee
 
for Quality Assurance (HEDIS 2000) shows that Health
 
Plans from across the United States averaged 75.07 +
 
11.50%. Although this figure appears better than the
 
regional comparison figure, no statement can be made
 
about significance in the above cases.
 
The frequency of Retinal Screening Examinations,
 
Urinary Microalbumin, measurements, and LDL-Cholesterol
 
measurements illustrates the surrogate measures of
 
Quality of Care for this population. These.are the same
 
measures used by national Quality Assurance organizations
 
for ranking Managed.Care Organizations. The frequency of
 
Retinal Screening Examinations within a one-year period
 
was 81.32% for the study group. The national data from
 
the HEDIS data set of NCQA gives a value of 45.30 +
 
15.00%. The frequency of Urinary Microalbumin screening
 
was 93.41% for the study group and 36.08 + 14.38%,for the
 
HEDIS data set of NCQA. The frequency of LDL-Cholesterol
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Screening was 96;.:70% for the sttidy group and 69.09 ,
 
:11.15%; for the HEbiS data set of:NCQi\.;
 
Table ,2 .illustrates the.:.changes in .glucose control
 
of the. study group during the thrpe and..six month . . ■ 
follow-up periods in this ihterventi.on. The. bar graphs
 
are skewed;to the left;, (oorre.spbnding'to poor control) in
 
the baseline (pre-intervehtipnl;;chart due,to the nature ­
of the study model t.hat pre-selected ., for poorly ; .
 
controlled at-risk diabetics with a HbAlc of 8.9% and ,
 
above in order to qualify for this study. The subsequent
 
three-month and six-month post intervention bar graphs
 
illustrate the profound change between the statistical
 
qua.rtiies .for . Poor, -Fair., Good,, and Excellent glucose
 
control .occurring over time.
 
Tables 3, . 4, and. 5 focus upon the intent to treat
 
section, of the- study. There were 85 study .participants
 
that performed a Urinar-y Microalbumin.within a one-year..
 
■period 	around the study dates .: .0^^ number, there , were 
44 Confirmed positive Microalbumin measurements and 41 
confirmed negative .measuremehts, ■88.63% of. the positive 
group received appropriate treatment for their. 
Microalbumin. .Southern California Regional values for 
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Microalbumin treatment are 77.vSS + 2.18% in an unselected
 
diabetic population.
 
There were 88 study participants that performed an1 
LDL-Cholestexol measurement-within a one-year period 
around the , study dates .. Of this number, 62 were confirmed-
positive for abnormal.LDL-Cholesterol using the. Regional 
Guideline of > 130 mg/dl..; 72.58% of the .positivelgfoup ■ 
received appropriate treatment for their Choles.terol , 
abnormality. This compares with 77.59 + 8.39% in an. 
unselected diabetic population in the Southern California 
Region.. 
Theve were 7'4 study pafticipants.that pe.rfornied a
 
Screening Retinal Examination within a one-year period,
 
around the . study dates. These studies were reviewed by an
 
Ophthalmologist to determine the course of treatment..
 
81.32% of the study population received this evaluation.
 
National statistics . from the HEDIS data set of NC.QA gives
 
a comparison of 45.30.+ 15.00% in an unselected national
 
diabetic population.
 
The above data appears to support the hypothesis,
 
that the introduction of the Diabetes Nurse Care Managers
 
into the Outlying Medical Offices has had a positive
 
effect on the. care delivered to an at-risk diabetic
 
in
 
population selected for poor glucose control. These
 
finding will impact the decision to continue and to
 
increase the use of this model of care within our
 
healthcare system.
 
CHAPTER FOUR
 
CONCLUSIONS AND RECOMMENDATIONS
 
Conclusions
 
Analyses of effective models of care for diabetes
 
and other chronic diseases suggest that the design of
 
practice plays an important role in their success. The
 
design of the practice refers to the delegation of roles
 
within the practice team, the involvement of other
 
disciplines, the organization of visits and follow-up,
 
and the integration of psychoeducational interventions.
 
Efforts to redesign primary care to improve outcomes in
 
diabetes have varied widely in approach. The
 
interventions include increased involvement of
 
nonphysician providers (usually nurses or nurse
 
practitioners), or changing the design of visits or the
 
handling of follow-up. An early approach was the
 
establishment of a periodic mini-clinic in primary care
 
as described in the British Studies.
 
We chose to test the effectiveness of chronic care
 
clinics (mini-clinics) with relatively unselected primary
 
care practices and diabetic patients in an HMO, as
 
opposed to limiting the intervention to volunteer
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practices and highly motivated patients, in an attempt to
 
assess its practicality and effectiveness as a system
 
change strategy. Because potential study patients were
 
selected at random, not by virtue of their interest in
 
participating, we had to make compromises.in the
 
completeness of the baseline data to assure high rates of
 
participation.
 
The intention-to-treat analysis findings suggest
 
that participation in Diabetes Nurse Care Manager clinics
 
resulted in improved processes of care and somewhat
 
better health. All measures of the process of diabetes
 
care were better in the intervention group than in the
 
control group, and many reached statistical significance
 
Whereas chronic care clinics, as described by
 
Wagner, Austin, and Von Korff (1996), relied on existing
 
clinic personnel to deliver services. Diabetes Care
 
Management nurse played an important role in the present
 
study that must he considered when estimating the full
 
cost of the intervention. A Diabetes Care Management
 
nurse handled most of the Group Appointment clinic
 
organizational tasks, i.e., scheduling time, space, and
 
patients; organizing patient assessments and treatment
 
planning; and planning the group session. Our initial
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plan was to have the study staff gradually turn most of
 
these responsibilities over to practice staff, but this
 
training takes time and resources that were unavailable
 
at that time. Ultimately, several practices took on these
 
responsibilities. We suspect that the impact of
 
mini-clinics on clinical and health outcomes would have
 
been much greater if practice nurses had sufficient time
 
and training to provide clinical case management as
 
described in the work of the British Physicians. This may
 
explain the modest effects of chronic care clinics on
 
HbAlc and other health status indicators.
 
This study provides evidence that relatively
 
unselected primary care practices can he reorganized to
 
provide better care for patients with chronic illnesses
 
in a system with other enhancements, such as registries
 
and guidelines. A related model, the cooperative health
 
care clinic (31), has been shown to improve outcomes in
 
diabetic patients (32). The diabetes cooperative health
 
care clinics differed from the chronic care clinics in
 
that they were led by a diabetes nurse educator, they did
 
not involve the primary care team, and they conducted
 
most of their assessment, education, and other activities
 
in a group setting (32). Bringing groups of chronically
 
ill patients into special primary care sessions designed
 
to meet their clinical, educational, and psychosocial
 
needs appears to he a feasible and effective way of
 
improving their care.
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Table 1.OutcomesofCare intervention atBaseline,3Months,and6Months
 
Average Age(years) 56.2+ 11.2
 
Age Range(years) 33-84
 
Male/ Female 46/45
 
Comorbidities
 
1 14
 
2 3
 
3 1
 
Ave. HbAic(Pre- 10.34+1.33
 
Intervention)
 
Ave. HbAic(3 Months) 8.34+1.61
 
Ave. HbAic(6 Months) 8.09+ 1.52
 
#Having at least 1 HbAic 79(86.81%) ,
 
# Having at least2 HbAic 27(27.67%)
 
#With Eye Exam W/l 1 Year 74(81.31%)
 
#With Urine MA W/l 1 Year 85(93.41%)
 
#With LDL-Chol W/l 1 Year 88(96.70%)
 
Table 2.Change in Glucose Control During the Study
 
Period.
 
100
 
1
 80
 
Pre- 60 
y 1 
Intervention 40 X 
X' 
20 X 
0
 
Poor Fair Good Excellent
 
Glucose Control
 
25 
20 
3 Months 
Intervention 
15 
10 ■ 
■ 
Poor Fair Good 
Glucose Control 
Excellent 
12
 
6 Months
 ■ 
Intervention
 
Poor Fair Good Excellent
 
Glucose Control
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Table 3.TreatmentofAbnormal MIcroalbumIn
 
N =85 Having Urinary MA Performed within 1 Year
 
Study Group Control Group
 
39Treated (88.63%) and (11.36%) 77.35+2.78% Southern California Region
 
44 Measured Not Treated
 
Table 4.TreatmentofAbnormal LDL-Cholesterol.
 
N =88 Having LDL-Cholesterol Performed within 1 Year.
 
77+ If using LDL Cutoff> 100 mg/dl
 
62+ If using LDL Cutoff> 130 mg/dl
 
Study Group Control Group
 
47Treated (61.03%) and (39.97%) None Available
 
77 Measured Not Treated
 
Study Group Control Group
 
45 Treated (72.58%) and (27.42%) 62 77.59 +8.39% Southern California Region
 
Measured NotTreated
 
Table 5.Frequency of Retinal Eye Examination and Evaluation.
 
N =74 Having Eye Screening and Evaluation within one Year.
 
Study Group Control Group
 
74 Evaluated(81.31%)and(18.68%) 44.1 +7.48% Southern California Region
 
91 Population NotTreated
 
APPENDIX B
 
EXHIBITS
 
87
 
Exhibit 1.Business and Professions Code,Section 2725.Nursing Practice Act.
 
Article 2.Scope ofRegulation
 
2725.Legislative Declaration;Practice ofNursing;Functions
 
(a)~In amending this section atthe 1973\N74 session,the Legislature recognizes that
 
nursing is a dynamic field,the practice ofwhich is continually evolving to include
 
more sophisticated patient care activities,it is the intent ofthe Legislature in
 
amending this section atthe 1973\N74 session to provide clear legal authority for
 
functions and procedures that have comrnon acceptance and usage.It is the legislative
 
intent also to recognize the existence ofoverlapping functions between physicians and
 
registered nurses and to permit additionalsharing offunctions within organized health
 
care systems that provide for collaborationbetween physicians and registered nurses.
 
These organized health care systems include,but are not limited to,health facilities
 
licensed pursuantto Chapter2(commencing with Section 1250)ofDivision2ofthe
 
Health and Safety Code,clinics,home health agencies,physicians'offices,and public
 
or community health services.
 
(b)~The practice ofnursing within the meaning ofthis chapter meansthose functions,
 
including basic health care,that help people cope with difficulties in daily livingthat
 
are associated with their actual or potential health or illness problems or the treatment
 
thereof,and that require a substantial amountofscientific Iqiowledge or technical
 
skill,including all ofthe following:
 
(1)~Directand indirect patient care services that ensure the safety,comfort,personal
 
hygiene,and protection ofpatients;and the performanceofdisease prevention and
 
restorative measures. r
 
(2)~Direct and indirect patient care services,including,but notlimited to,the
 
administration ofmedications and therapeutic agents,necessary to implementa
 
treatment,disease prevention,or rehabilitative regimen ordered by and withinthe
 
scope oflicensme ofa physician,dentist, podiatrist,or clinical psychologist,as
 
defined by Section 1316.5 ofthe Health and Safety Code.
 
(3)~The performance ofskin tests,immunization techniques,and the withdrawal of
 
human blood from veins and arteries.
 
(4)~Observation ofsigns and symptomsofillness,reactions to treatment,general
 
behavior,or general physical condition,and(A)determination ofwhether the signs,
 
symptoms,reactions,behavior,or general appearance exhibit abnormal characteristics,
 
and(B)implementation,based on observed abnormalities,ofappropriate reporting,or
 
referral,or standardized procedures,or changesin treatmentregimen in accordance
 
with standardized procedures,or the initiation ofemergency procedures.
 
(c)~"Standardized procedures," as used in this section^ means either ofthe following:
 
(l)~Policies and protocols developed by a health facility licensed pursuantto Chapter
 
2(commencing with Section 1250)ofDivision2ofthe Health and Safety Code
 
through collaboration among administrators and health professionals including
 
physicians and nurses.
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(2)~Policies and protocols developed through collaboration among administrators and
 
health professionals,including physicians and nurses,by an organized health care
 
system which is nota health facility licensed pursuantto Chapter2(commencing with
 
Section 1250)ofDivision2ofthe Health and Safety Code.
 
The policies and protocols shall be subjectto any guidelines for standardized
 
procedures thatthe Division ofLicensing ofthe Medical Board ofCalifornia and the
 
Board ofRegistered Nursing mayjointly promulgate.Ifpromulgated,the guidelines
 
shall be administered by the Board ofRegistered Nursing.
 
(d)~Nothing in this section shall be construed to require approval ofstandardized
 
procedures by the Division ofLicensing ofthe Medical Board ofCalifornia,or by the
 
Board ofRegistered Nursing.
 
(Amended by Stats. 1995,c.279(AB 1471),§ 15; Stats. 1996,c. 124(AB 3470),§ 2.)
 
2725.1.Dispensing Drugs or Devices;Registered Nurses;Limitations
 
Notwithstanding any other provision oflaw,a registered nurse may dispense drugsor
 
devices upon an order by a licensed physician and surgeon whenthe nurse is
 
functioning within a licensed clinic as defined in paragraphs(1)and(2)ofsubdivision
 
(a)ofSection 1204 of,or within a clinic as defined in subdivision(b)or(c)ofSection
 
1206,ofthe Health and Safety Code.
 
No clinic shall employ a registered nurse to perform dispensing duties exclusively.No
 
registered nurse shall dispense drugs in a pharmacy,keep a pharmacy,open shop,or
 
drugstore for the retailing ofdrugs or poisons.No registered nurse shall compound
 
drugs. Dispensing ofdrugs by a registered nurse,excepta nurse practitioner who
 
functions pursuantto a standardized procedure described in Section 2836.1,or
 
protocol,shall not include substances included in the California Uniform Controlled
 
Substances Act(Division 10(commencing with Section 11000)ofthe Health and
 
Safety Code).Nothing in this section shall exempta clinic from the provisions of
 
Article 3.5(commencing with Section 4063)ofChapter 9.
 
(Amended by Stats. 1999,c.83(SB 966),§ 3;Stats. 1999,c.914(AB 1545),§ 1.)
 
2725.3.Health Facility;Use ofUnlicensed Personnel in Lieu ofRegistered Nurse;
 
Authorized Acts
 
(a)~A health facility licensed pursuantto subdivision(a),(b),or(f),ofSection 1250
 
ofthe Health and Safety Code shall not assign unlicensed personnel to perform
 
nursing functions in lieu ofa registered nurse and may not allow unlicensed personnel
 
to perform functions underthe direct clinical supervision ofa registered nurse that
 
require a substantial amountofscientific knowledge and technical skills,including,
 
butnotlimited to,any ofthe following:
 
(1)~Administration ofmedication.
 
(2)—Venipuncture or intravenous therapy.
 
(3)~Parenteral or tube feedings.
 
(4)~Invasive procedures including inserting nasogastric tubes,inserting catheters,or
 
tracheal suctioning.
 
(5)—Assessmentofpatient condition.
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(6)~Educating patients and their families concerning the patient\'s health care
 
problems,including postdischarge care.
 
(7)~Moderate complexity laboratory tests.
 
(b)~This section shall not preclude any personfrom performing any act or function
 
that he or she is authorized to perform pursuantto Division2(commencing with
 
Section 500)or pursuantto existing statute or regulation as ofJuly 1, 1999.
 
(Added by Stats. 1999,c.945(AB 394),§ 2.)
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 Exhibit 2.Raw data Prior to Analysis.
 
No SEX AGE PRE FIRST SEGO COM LAST MA MA> AGERX LAST LDL LDL+ LIPID EYE 
ND ORB RX EXAM 
V1 M 57 11.2 8.8 c 10/01 Y Y 10/01 Y Y yes 
V2 M 68 9.8 6.6 7.3 ^ 08/01 Y Y 08/01 Y Y yes 
V3 M 58 13.1 6.9 08/01 N NA 08/01 Y Y pend 
V4 F 48 10.3 8.6 09/01 . N NA 09/01 N NA pend 
V5 M 73 9.3 10.2 01/01 N NA 01/01 Y N yes 
V6 M 65 11.6 8.8 8.8 08/01 N NA 08/01 Y Y yes 
V7 59 9.4 6.3 H 10/01 Y Y 10/01 N NA yes 
V8 F 79 11 . 9.4 7.4 10/01 Y Y 10/01 Y N 
V9 33 8.9 , 05/01 Y Y 05/01 Y N yes 
V10 F 83 9 8.6 8.2 04/01 Y Y 04/01 Y N , pend 
V11 84 13 10.5 8.2 0 Y 07/01 Y Y no . 
V12 63 8.9 8.2 8.5 R 08/01 Y Y 08/01 Y* N yes 
V13 M 68 9.3 8.8 8.2. 04/01 Y Y 09/01 N NA yes 
V14 M 60 10 7.4 08/01 N NA 10/01 Y­ Y yes 
V15 M 47 11.8 8.4 08/01 Y Y 08/01 Y Y yes 
V16 M 46 9.3 6.9 6.2 08/01 : N NA 08/01 N NA yes 
V17 M 35 14 0 03/01 Y Y 03/01 Y Y yes 
V18 M 59 9.3 9.2 07/01 Y N 05/01 Y* N yes 
V19 M 47 13.2 6.7 08/01 . N NA 08/01 Y Y no 
V20 M 40 11.9 13.1 08/01 Y Y 08/01 Y Y yes 
V21 40 9.4 6.5 07/01 Y Y 06/01 Y Y yes 
V22 F 62 10.5 N NA 10/01 Y N yes 
V23 56 11 8.3 9.3 10/01 Y Y 05/01 Y Y no 
V24 F 56 9.1 8.4 6.7 02/01 N NA 10/01 Y N yes 
V25 76 11.5 10.7 8.2 HO 08/01 Y Y 09/01 Y Y yes 
V26 69 9.3 6.6 7.1 01/01 N NA 12/00 Y Y yes 
Mil F 59 10.4 12.1 01/01 Y N 04/01 Y N yes 
V28 49 11.1 5.5 5.5 08/01 N NA , 08/01 N NA yes 
V29 M 61 11.1 9.5 9.2 C 07/01 Y Y 07/01 Y Y yes 
V30 M 83 10 7.8 KG Y 07/01 Y Y yes 
y31 M 69 1Q.5 8.3 7.6 08/01 Y Y 08/01 Y Y yes 
V32 M 47 12.7 5.5 09/01 Y Y 09/01 N NA yes 
V33 F 64 10 9.8 10.2 08/01 Y Y 08/01 Y N yes 
V34 F 68 10.1 7.1 7.6 05/01 Y Y 08/01 Y Y yes 
V35 F 68 9.8 02/01 Y N 02/01 Y N yes 
V36 M 47 10.6 7.2 6.1 09/01 Y N 09/01 Y Y yes 
V37 M 64 9.3 8.5 8.2 05/01 Y Y 09/01 N NA yes 
V38 F 48 9.7 8.4 8.8 07/01. N NA 06/01 N NA yes 
V39 M 60 9.4 8.1 10/01 N NA 10/01 Y* N no 
V40 F 53 13.5 14.2 07/01 N NA 03/01 Y Y yes 
V41 F 34 11.5 7.1 03/01 N NA 06/01 Y* N yes 
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No SEX AGE PRE FIRST SECO COM LAST MA MA+ ACERX LAST LDL LDL+ LIPID EYE
 
ND ORB RX EXAM 
V42 M 58 9.5 9.1 9.7 HO Y 11/00 Y Y no 
V43 M 59 8.9 5.8 08/01 N NA 08/01 Y* N yes 
V44 M 56 12.6 8.6 7.9 0 08/01 Y Y 08/01 Y* Y yes 
V45 F 61 12.7 11.2 6.2 ; 08/01 N NA 08/01 Y* N yes 
V46 M 57 9.7 5.8 08/01 N NA 08/01 Y N yes 
V47 M 47 13.1 6 07/01 N NA 07/01 N NA yes 
V48 F 61 9.6 7.8 7.2 08/01 N NA 08/01 Y Y yes 
V49 F 68 8.9 7.9 6.9 R 08/01 N NA 08/01 Y Y yes 
V50 F 61 10 6.3 07/01 N NA 07/01 Y N yes 
V51 F 60 10.7 10.6 08/01 Y N 10/01 Y N yes 
V52 F 41 9.7 10/01 ; N; NA , 10/01 Y Y yes 
V53 M 51 12.3 7.3 06/01 N NA 05/01 Y* N yes 
V54 F 50 11 7.2 : 09/01 N NA ; 09/01 Y* N yes 
V55 M 55 13.8 6.9 10/01 N NA 10/01 N NA yes 
C1 M 53 9 8.2 01/01 N NA 01/01 Y Y yes 
C2 M 41 9.6 10/01 N NA 10/01 Y* N yes 
C3 F 51 9.8 Y Y Y Y no 
C4 F 43 8.9 8.3 09/01 N NA 09/01 Y N yes 
C5 F 57 8.9 11.1 10/01 Y Y 10/01 Y N no 
G6 M 42 9.6 8.1 08/01 N NA Y* N yes 
C7 M 50 9.2 09/01 N NA 09/01 N NA yes 
C8 F 58 9.3 7.2 08/01 Y Y 08/01 Y N no 
C9 M 54 10 8.8 8 09/01 Y Y 06/01 Y Y no 
C10 M 70 10.2 8.7 0 08/01 Y Y 08/01 Y Y yes 
C11 M 54 9.8 8.4 08/01 Y Y 08/01 Y N yes 
C12 M 72 10.5 8.5 0 09/01 N NA 08/01 Y Y yes 
C13 F 70 11.1 7.8 HRC 08/01 Y Y 08/01 Y Y yes 
C14 F 61 11 7.1 09/01 N NA 09/01 Y Y yes 
C15 M 55 9.2 9.9 10.6 08/01 Y Y 08/01 Y Y yes 
C16 M 62 9.4 6.9 08/01 N NA 08/01 Y Y yes 
C17 F 49 9.2 10.2 08/01 Y Y 08/01 Y Y yes 
C18 F 52 9.6 9.4 08/01 Y Y 06/01 Y Y no 
C19 M 42 12.2 7 08/01 Y Y 04/01 YV N yes 
C20 M 71 9.1 9.2 08/01 Y Y 08/01 N NA yes 
C21 M 49 10 10.3 09/01 N NA 09/01 Y Y yes 
C22 M 46 10.6 9.2 08/01 N NA 08/01 Y* N yes 
C23 F 47 10.5 7.9 08/01 N NA 08/01 Y Y no 
C24 57 9.2 8.8 08/01 N NA 08/01 Y* N yes 
C25 F 57 8.9 9.3 09/01 Y Y 09/01 Y Y yes 
C26 F 40 10.5 7.4 09/01 Y ? 09/01 Y* ? no 
C27 F 38 9.3 10.2 09/01 N NA 09/01 Y N yes 
C28 F 59 7.8 8.1 10/01 N NA 10/01 Y Y yes 
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No SEX AGE PRE FIRST SECO COM LAST MA MA+ AGE RX LAST LDL LDL+ LIPID EYE
 
ND ORB RX EXAM 
C29 M 41 9.4 11 N NA no 
C30 F 51 10.8 10 0 10/01 Y Y 10/01 Y Y yes 
C31 F 60 10 9.1 0 09/01 N NA 09/01 Y MC 
OC 
Y no 
C32 F 46 11.7 03/01 Y Y 03/01 Y" Y yes 
C33 M 55 9.7 0 08/01 Y Y 08/01 Y Y yes 
C34 M 65 9.1 9 0 03/01 Y Y 10/01 Y Y no 
C35 F 63 10 11/00 N NA 11/00 Y Y no 
G36 M 46 10.3 08/01 Y Y 08/01 N NA no 
# 46M 5117 941 609 267 85 Y=44 88 74 
91 45F N=41 Y*=15 
56.2 10.3 8.34 8.09 0.934066 0.967033 N= 14 0.8131868 
93
 
REFERENCES
 
American Diabetes Association. (1996). Diabetes: 1996
 
Vital Statistics.
 
American Diabetes Association. (1996). Direct and
 
Indirect Costs of Diabetes.
 
American Diabetes Association. (1998). Medical Management
 
of Type 2 Diabetes, (4th ed.).
 
American Diabetes Association. (2001). Clinical practice
 
recommendations - 2001. Diabetes Care, 24, S1-S95.
 
American Diabetes Association. (2001). The Impact of
 
Diabetes. Available October 16, 2001, from
 
http://www.diabetes.org/main/application/commercewf?
 
origin=*.jsp&event=link(Bl_l)
 
American Medical Association. (2000). Accrediting
 
Committee for Graduate Medical Education Guidelines
 
(Green Book).
 
Aubert, R. E., Herman, W. H., Waters, J., Moore, W.,
 
Button, D., Peterson. B. L., Bailey, C. M., &
 
Kaplan, J.P. (1998). Nurse case management to
 
improve glycemic control in diabetic patients in a
 
health maintenance organization: A randomized,
 
controlled trial. Annals of Internal Medicine, 129,
 
605-612
 
Baker, A. M., Lafata, J. E., Ward, R. E., Whitehouse, F.,
 
& Divine, G. (2001). A web-based diabetes care
 
management support system. Journal on Quality
 
Improvement, 27, 179-190.
 
Batalden, P. et al. (1997). Continually improving the
 
health and value of health care for a population of
 
patients: the panel management process. Quality
 
Management in Health Care, 5, 41-51.
 
Dalzell, M. (1998). Just what the devil is
 
population-based care? Managed Care, 7, 55-60.
 
94
 
  
 
 
Farmer, A., & Coulter, A. (1990)v Organization of care
 
for diabetic patients in general practice.: influence
 
on hospital admission. British Journal of.General
 
Practice, 40, 56-58.
 
Frame, P. S. (1995).. Computerized health,maintenance
 
tracking.systems: A clinician's guide to necessary
 
: and optional features. A report from the American
 
Cancer Society Advisory Group on .Preventive Health ,
 
Care Reminder Systems. Journal of the American Board
 
: of Family Practice,' 8, 221r229.;
 
Greenfield, S., Rogers,. W.,; Mango,tich:., M,., Carney, M. F.,
 
& Tarlov, A. R. (1995). Outcomes' o,f patients with
 
hypertension and.non-insulin-dependent diabetes
 
mellitus treated by. different systems and
 
specialties: Results from the medical outcomes
 
study. Journal of the American Medical Association,
 
274, 1436-1444.1
 
Gurnee, M. C., ,& Da Silva, R. V; (1.997) Constructing
 
disease mariagement'programs. Managed Care, 6, 67-73.
 
Hayes, T. M., & Harries, J. (1984). Randomized controlled
 
trial of routine hospital clinic care, versus,routine
 
general practice care for type II diabetics. British
 
. . Medical Journal, 289, 728:-730
 
Ho, M., Marger, . M.,. Beart, J., Yip, ,1., & Shekelle, P.
 
(1997). Is the quality of diabetes care better in a
 
diabetes clinic or in a general medicine clinic? .
 
Diabetes Care, 20,0472-475. . )
 
Kaiser-Permanente Intranet. Website.' (n.d.). Kaiser 
Permanente Stat. Facts.September .2001. Available. 
: September 27> 2001, from, 
http://insidekp.kp.org/insidekp/facts/statfacts/inde 
X..htm ' ;0\ ■ 
Khoury, A. T., Churgin, P., & Strawn, K. (1998). . ; .
 
Population health management with computerized
 
patient records. Effective Clinical Practice, 1,
 
. 61-65.. ,
 
95
 
  
Koperski, M. (1992), Systematic care of diabetic patients 
in one general practice How much does ^it cost? 
British Journal, of ■ General Practice, 42, 370-3,72. 
MacKinnon, M. (1990). General practice diabetes care: the
 
.past, the present and the future. Diabetes Medicine,
 
7, 171-172., ,
 
Martin, T. L., Selby, J. ,V., & Zhang, D. (1995). ,
 
Physician and patient prevention practices in NIDDM
 
in a large urban managed-care organization. Diabetes
 
Care, 18, 1124-1132.
 
McCullough, D. K., Price, M. J., Hindmarsh, M., & Wagner,
 
E. H. (1998). A population-based approach to
 
diabetes management in a primary care setting:, early
 
results,, and lessons learned. Effective Clinical
 
Practice, 1, 12,-22.
 
Milgram, S. (197,4)., C)bedience to Authority. .New York:
 
Harper & Row Publishers, Inc.. , ,,
 
National results for selected 2000, HEDIS( and,
 
HEDIS/CAHPS( measures. National Committee for
 
Quality Assurance; Available May 8, 2001, from,
 
http://www.,.ncqa.org/programs/HEDlS/digbetesOO.htm ,
 
Nursing. Board of California, (n.d.). Nursing Scope of
 
Practice.: Business and. Professions Code,. • Section
 
2725. Available October 18,: 2000, from,
 
http://wwwirn.ca.gov/practact/b&p.htm
 
Ofnstein, : S., M., Garr, D. R., Jenkins, R. G.,, Musham, C.,
 
.	 Hamadeh, G., .& Lancaster, C. (1995). Implementation
 
and evaluation of a computer-based preventive
 
services system,. Family Medicine, 27, 260-266.
 
Peters, A. L., & Davidson, M., B. (1998). Application of a
 
diabetes managed-care program: The feasibility of
 
using nurses and computer system to,provide
 
effective care. Diabetes Care, 21, 1037-1043.
 
Peters, A. L., Davidson, M. B., & Ossorio, R. L. (1,995).
 
. Manaigement of patients, with diabetes by nurses with
 
support of subspecialists. HMO Practice,;9, 8-13.
 
96
 
Pringle, M., Ward, P., & Chilvers, C. (1993). Influences
 
on control in diabetes mellitus: patient, doctor,
 
practice, or delivery of care? British Medical
 
Journal, 306, 630-634.
 
Shea, S., Du Mouchel, W., & Bahamonde, L. (1996). A
 
meta-analysis of 16 randomized controlled trials to
 
evaluate computer-based clinical reminder systems
 
for preventive care in the ambulatory setting.
 
Journal of the American Medical Informatics
 
Association, 3, 399-408.
 
Stedman's Medical Dictionary, (22nd ed.). (1972).
 
Baltimore, MD: Williams and Wilkins Company.
 
The Diabetes Control and Complications Trial (DCCT)
 
Research Group (1993). The effect of intensive
 
treatment of diabetes on the development and
 
progress should of long-term complications in
 
insulin dependence diabetes mellitus. New England
 
Journal of Medicine, 329, 977-986.
 
UK Prospective Diabetes Study (UKPDS). (1998). Group:
 
Intensive blood glucose control with sulphonylureas
 
or insulin compared with conventional treatment and
 
risk of complications in patients with Type 2
 
diabetes (UKPDS 33). Lancet, 352, 837-853.
 
Verlato, G., Muggeo, M., Bonora, E., Corbellini, M.,
 
Bressan, F., & de Marco, R. (1996). Attending the
 
diabetes center is associated with increased 5-year
 
survival probability of diabetic patients: the
 
Verona Diabetes Study. Diabetes Care, 19, 211-213
 
Wagner, E. H. et al. (2001). Chronic care clinics for
 
diabetes in primary care. Diabetes Care, 25,
 
695-700.
 
Wagner, E. H., Austin, B. T., & Von Korff, M. (1996).
 
Improving outcomes in chronic illness. Managed Care
 
Quarterly, 4, 12-25
 
Wagner, P. H. (1998). More than a case manager. Annals of
 
Internal Medicine, 129, 654-656.
 
97
 
Weinberger, M., Kirkman, M. S., Samsa, G. P., Shortliffe,
 
P. A., Landsman, P. B., Cowper, P. A., Simel, D. L.,
 
Peussner, J. R. (1995). A,nurse-coordinated
 
intervention for primary care patients with
 
non-insulin-dependent diabetes mellitus: impact on
 
glycemic control and health-related quality of life.
 
Journal of General Internal Medicine, 10, 59-66.
 
98
 
